CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: avobenzone
Accession: CHEBI:134751
browse the term
Synonyms: related_synonym: Formula=C20H22O3; InChI=1S/C20H22O3/c1-20(2,3)16-9-5-14(6-10-16)18(21)13-19(22)15-7-11-17(23-4)12-8-15/h5-12H,13H2,1-4H3; InChIKey=XNEFYCZVKIDDMS-UHFFFAOYSA-N; SMILES=C(CC(=O)C1=CC=C(C=C1)OC)(=O)C2=CC=C(C=C2)C(C)(C)C; butylmethoxydibenzoylmethane; photoplex
xref: CAS:70356-09-1; Drug_Central:4242
xref_mesh: MESH:C049935
G
Aadacl2
arylacetamide deacetylase-like 2
decreases expression
ISO
avobenzone results in decreased expression of AADACL2 mRNA
CTD
PMID:31016361
NCBI chr 2:150,344,307...150,365,033
Ensembl chr 2:150,344,307...150,365,033 Ensembl chr 2:150,344,307...150,365,033
G
Aass
aminoadipate-semialdehyde synthase
increases expression
ISO
avobenzone results in increased expression of AASS mRNA
CTD
PMID:31016361
NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
G
Abca12
ATP binding cassette subfamily A member 12
decreases expression
ISO
avobenzone results in decreased expression of ABCA12 mRNA
CTD
PMID:31016361
NCBI chr 9:78,521,477...78,693,421
Ensembl chr 9:78,522,464...78,693,028
G
Abhd3
abhydrolase domain containing 3, phospholipase
increases expression
ISO
avobenzone results in increased expression of ABHD3 mRNA
CTD
PMID:31016361
NCBI chr18:1,892,413...1,946,840
Ensembl chr18:1,892,413...1,946,840
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
ISO
avobenzone results in increased expression of ACAT2 mRNA
CTD
PMID:31016361
NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
G
Acly
ATP citrate lyase
increases expression
ISO
avobenzone results in increased expression of ACLY mRNA
CTD
PMID:31016361
NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
G
Acss2
acyl-CoA synthetase short-chain family member 2
increases expression
ISO
avobenzone results in increased expression of ACSS2 mRNA
CTD
PMID:31016361
NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
increases expression
ISO
avobenzone results in increased expression of ADAMTS1 mRNA
CTD
PMID:31016361
NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
G
Adgre5
adhesion G protein-coupled receptor E5
increases expression
ISO
avobenzone results in increased expression of ADGRE5 mRNA
CTD
PMID:31016361
NCBI chr19:24,854,981...24,875,712
Ensembl chr19:24,855,299...24,875,137
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; T 0070907 affects the reaction [avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]
CTD
PMID:31016361 PMID:32407875
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
G
Afap1
actin filament associated protein 1
increases expression
ISO
avobenzone results in increased expression of AFAP1 mRNA
CTD
PMID:31016361
NCBI chr14:79,923,132...80,035,096
Ensembl chr14:79,919,717...79,988,110
G
Aif1l
allograft inflammatory factor 1-like
decreases expression
ISO
avobenzone results in decreased expression of AIF1L mRNA
CTD
PMID:31016361
NCBI chr 3:9,237,944...9,262,628
Ensembl chr 3:9,237,944...9,262,628
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
avobenzone results in increased expression of AKR1C2 mRNA
CTD
PMID:31016361
NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
avobenzone results in increased expression of AKR1C3 mRNA
CTD
PMID:31016361
NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
increases expression
ISO
avobenzone results in increased expression of ALDH6A1 mRNA
CTD
PMID:31016361
NCBI chr 6:108,146,552...108,167,185
Ensembl chr 6:108,146,582...108,167,185
G
Ang
angiogenin
increases expression
ISO
avobenzone results in increased expression of ANG mRNA
CTD
PMID:31016361
NCBI chr15:28,022,926...28,028,636
G
Ank2
ankyrin 2
decreases expression
ISO
avobenzone results in decreased expression of ANK2 mRNA
CTD
PMID:31016361
NCBI chr 2:231,224,643...231,522,655
Ensembl chr 2:231,226,949...231,648,122
G
Antxr1
ANTXR cell adhesion molecule 1
increases expression
ISO
avobenzone results in increased expression of ANTXR1 mRNA
CTD
PMID:31016361
NCBI chr 4:118,946,267...119,131,202
Ensembl chr 4:118,946,268...119,131,202
G
Aopep
aminopeptidase O
decreases expression
ISO
avobenzone results in decreased expression of AOPEP mRNA
CTD
PMID:31016361
NCBI chr17:507,389...825,062
Ensembl chr17:507,377...821,582
G
Ar
androgen receptor
affects binding multiple interactions
ISO
avobenzone binds to AR protein avobenzone binds to and results in decreased activity of AR protein
CTD
PMID:15537743 PMID:28115641
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
G
Araf
A-Raf proto-oncogene, serine/threonine kinase
increases expression
ISO
avobenzone results in increased expression of ARAF mRNA
CTD
PMID:31016361
NCBI chr X:1,369,534...1,391,603
Ensembl chr X:1,379,194...1,390,873
G
Arhgap26
Rho GTPase activating protein 26
decreases expression
ISO
avobenzone results in decreased expression of ARHGAP26 mRNA
CTD
PMID:31016361
NCBI chr18:31,807,052...32,557,176
Ensembl chr18:31,812,109...32,207,801
G
Arid3b
AT-rich interaction domain 3B
increases expression
ISO
avobenzone results in increased expression of ARID3B mRNA
CTD
PMID:31016361
NCBI chr 8:62,569,601...62,616,837
Ensembl chr 8:62,569,528...62,616,828
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
avobenzone results in decreased expression of ASNS mRNA
CTD
PMID:31016361
NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
G
Asph
aspartate-beta-hydroxylase
increases expression
ISO
avobenzone results in increased expression of ASPH mRNA
CTD
PMID:31016361
NCBI chr 5:22,577,680...22,799,333
Ensembl chr 5:22,577,675...22,799,349
G
Asphd2
aspartate beta-hydroxylase domain containing 2
decreases expression
ISO
avobenzone results in decreased expression of ASPHD2 mRNA
CTD
PMID:31016361
NCBI chr12:50,269,347...50,279,855
Ensembl chr12:50,269,347...50,279,745
G
Ass1
argininosuccinate synthase 1
decreases expression
ISO
avobenzone results in decreased expression of ASS1 mRNA
CTD
PMID:31016361
NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
G
Atp10b
ATPase phospholipid transporting 10B (putative)
decreases expression
ISO
avobenzone results in decreased expression of ATP10B mRNA
CTD
PMID:31016361
NCBI chr10:28,449,248...28,862,423
Ensembl chr10:28,449,335...28,864,255
G
Atp6v0d2
ATPase H+ transporting V0 subunit D2
increases expression
ISO
avobenzone results in increased expression of ATP6V0D2 mRNA
CTD
PMID:31016361
NCBI chr 5:33,843,591...33,892,446
Ensembl chr 5:33,843,519...33,892,462
G
Bambi
BMP and activin membrane-bound inhibitor
decreases expression
ISO
avobenzone results in decreased expression of BAMBI mRNA
CTD
PMID:31016361
NCBI chr17:56,905,419...56,909,675
Ensembl chr17:56,905,112...56,909,992
G
Bbs12
Bardet-Biedl syndrome 12
decreases expression
ISO
avobenzone results in decreased expression of BBS12 mRNA
CTD
PMID:31016361
NCBI chr 2:124,048,513...124,057,026
Ensembl chr 2:124,054,282...124,056,795
G
Bcar3
BCAR3 adaptor protein, NSP family member
increases expression
ISO
avobenzone results in increased expression of BCAR3 mRNA
CTD
PMID:31016361
NCBI chr 2:226,563,050...226,679,449
Ensembl chr 2:226,563,050...226,679,438
G
Bcdin3d
BCDIN3 domain containing RNA methyltransferase
decreases expression
ISO
avobenzone results in decreased expression of BCDIN3D mRNA
CTD
PMID:31016361
NCBI chr 7:141,132,106...141,136,700
Ensembl chr 7:141,132,133...141,136,700
G
Bcl6b
BCL6B, transcription repressor
decreases expression
ISO
avobenzone results in decreased expression of BCL6B mRNA
CTD
PMID:31016361
NCBI chr10:56,834,363...56,840,058
Ensembl chr10:56,834,364...56,839,437
G
Brd3os
BRD3 opposite strand
decreases expression
ISO
avobenzone results in decreased expression of BRD3OS mRNA
CTD
PMID:31016361
NCBI chr 3:5,991,840...5,993,910
G
Btbd7
BTB domain containing 7
decreases expression multiple interactions
ISO
avobenzone results in decreased expression of BTBD7 mRNA avobenzone inhibits the reaction [IFI27 mRNA results in increased expression of BTBD7 mRNA]; IFI27 mRNA inhibits the reaction [avobenzone results in decreased expression of BTBD7 mRNA]
CTD
PMID:29981360
NCBI chr 6:126,658,398...126,748,497
Ensembl chr 6:126,661,634...126,710,858
G
Calhm6
calcium homeostasis modulator family member 6
increases expression
ISO
avobenzone results in increased expression of CALHM6 mRNA
CTD
PMID:31016361
NCBI chr20:27,681,138...27,683,580
Ensembl chr20:27,681,036...27,682,861
G
Calml5
calmodulin-like 5
decreases expression
ISO
avobenzone results in decreased expression of CALML5 mRNA
CTD
PMID:31016361
NCBI chr17:70,044,956...70,045,886
G
Calr
calreticulin
increases expression
ISO
avobenzone results in increased expression of CALR mRNA
CTD
PMID:31016361
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
decreases expression
ISO
avobenzone results in decreased expression of CAMK1D mRNA
CTD
PMID:31016361
NCBI chr17:76,532,611...76,938,956
Ensembl chr17:76,532,611...76,938,956
G
Cbs
cystathionine beta synthase
decreases expression
ISO
avobenzone results in decreased expression of CBS mRNA
CTD
PMID:31016361
NCBI chr20:10,361,987...10,386,663
Ensembl chr20:10,361,988...10,386,751
G
Ccbe1
collagen and calcium binding EGF domains 1
increases expression
ISO
avobenzone results in increased expression of CCBE1 mRNA
CTD
PMID:31016361
NCBI chr18:61,758,754...62,013,194
Ensembl chr18:61,759,289...61,788,863
G
Ccdc125
coiled-coil domain containing 125
decreases expression
ISO
avobenzone results in decreased expression of CCDC125 mRNA
CTD
PMID:31016361
NCBI chr 2:30,685,845...30,726,617
Ensembl chr 2:30,685,840...30,704,487
G
Ccdc167
coiled-coil domain containing 167
increases expression
ISO
avobenzone results in increased expression of CCDC167 mRNA
CTD
PMID:31016361
NCBI chr20:8,367,047...8,384,119
Ensembl chr20:8,369,331...8,384,088
G
Ccdc18
coiled-coil domain containing 18
decreases expression
ISO
avobenzone results in decreased expression of CCDC18 mRNA
CTD
PMID:31016361
NCBI chr14:1,664,620...1,701,269 NCBI chr14:2,510,184...2,612,070
Ensembl chr14:2,509,363...2,610,929
G
Ccdc71
coiled-coil domain containing 71
increases expression
ISO
avobenzone results in increased expression of CCDC71 mRNA
CTD
PMID:31016361
NCBI chr 8:117,236,933...117,251,573
Ensembl chr 8:117,246,376...117,250,280
G
Ccn1
cellular communication network factor 1
increases expression
ISO
avobenzone results in increased expression of CCN1 mRNA
CTD
PMID:31016361
NCBI chr 2:251,529,354...251,532,312
Ensembl chr 2:251,529,354...251,532,312
G
Ccna1
cyclin A1
decreases expression
ISO
avobenzone results in decreased expression of CCNA1 mRNA
CTD
PMID:31016361
NCBI chr 2:144,456,689...144,503,570
Ensembl chr 2:144,458,153...144,467,912
G
Ccng2
cyclin G2
increases expression
ISO
avobenzone results in increased expression of CCNG2 mRNA
CTD
PMID:31016361
NCBI chr14:16,267,572...16,276,068
Ensembl chr14:16,267,573...16,276,068
G
Cdk19
cyclin-dependent kinase 19
increases expression
ISO
avobenzone results in increased expression of CDK19 mRNA
CTD
PMID:31016361
NCBI chr20:45,458,499...45,598,799
Ensembl chr20:45,458,558...45,598,798
G
Cdkn2aipnl
CDKN2A interacting protein N-terminal like
increases expression
ISO
avobenzone results in increased expression of CDKN2AIPNL mRNA
CTD
PMID:31016361
NCBI chr10:37,422,647...37,432,082
Ensembl chr10:37,422,647...37,432,081
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
decreases expression
ISO
avobenzone results in decreased expression of CDKN2B mRNA
CTD
PMID:31016361
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
increases expression
ISO
avobenzone results in increased expression of CDKN2D mRNA
CTD
PMID:31016361
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression
ISO
avobenzone results in decreased expression of CEBPA mRNA
CTD
PMID:31016361
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
G
Cenpe
centromere protein E
decreases expression
ISO
avobenzone results in decreased expression of CENPE mRNA
CTD
PMID:31016361
NCBI chr 2:240,395,974...240,454,785
Ensembl chr 2:240,396,152...240,454,747
G
Cep104
centrosomal protein 104
increases expression
ISO
avobenzone results in increased expression of CEP104 mRNA
CTD
PMID:31016361
NCBI chr 5:171,262,278...171,294,560
Ensembl chr 5:171,262,278...171,294,559
G
Ces1d
carboxylesterase 1D
increases expression
ISO
avobenzone results in increased expression of CES1 mRNA
CTD
PMID:31016361
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
G
Cfap70
cilia and flagella associated protein 70
decreases expression
ISO
avobenzone results in decreased expression of CFAP70 mRNA
CTD
PMID:31016361
NCBI chr15:4,285,049...4,350,707
Ensembl chr15:4,285,052...4,350,714
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
decreases expression
ISO
avobenzone results in decreased expression of CHAC1 mRNA
CTD
PMID:31016361
NCBI chr 3:111,160,205...111,163,425
Ensembl chr 3:111,160,205...111,163,425
G
Chac2
ChaC glutathione specific gamma-glutamylcyclotransferase 2
decreases expression
ISO
avobenzone results in decreased expression of CHAC2 mRNA
CTD
PMID:31016361
NCBI chr14:115,383,906...115,391,757
Ensembl chr14:115,383,910...115,391,652
G
Chml
CHM like Rab escort protein
decreases expression
ISO
avobenzone results in decreased expression of CHML mRNA
CTD
PMID:31016361
NCBI chr13:93,740,759...93,742,624
G
Cited4
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
increases expression
ISO
avobenzone results in increased expression of CITED4 mRNA
CTD
PMID:31016361
NCBI chr 5:139,597,731...139,598,622
Ensembl chr 5:139,597,731...139,598,622
G
Cldn19
claudin 19
decreases expression
ISO
avobenzone results in decreased expression of CLDN19 mRNA
CTD
PMID:31016361
NCBI chr 5:138,300,692...138,307,982
Ensembl chr 5:138,300,107...138,305,683
G
Clhc1
clathrin heavy chain linker domain containing 1
decreases expression
ISO
avobenzone results in decreased expression of CLHC1 mRNA
CTD
PMID:31016361
NCBI chr14:113,968,563...114,008,015
Ensembl chr14:113,968,563...114,008,000
G
Clip2
CAP-GLY domain containing linker protein 2
increases expression
ISO
avobenzone results in increased expression of CLIP2 mRNA
CTD
PMID:31016361
NCBI chr12:25,172,957...25,236,935
Ensembl chr12:25,173,005...25,237,009
G
Clk3
CDC-like kinase 3
increases expression
ISO
avobenzone results in increased expression of CLK3 mRNA
CTD
PMID:31016361
NCBI chr 8:62,528,135...62,543,550
Ensembl chr 8:62,528,225...62,542,622
G
Cmtm7
CKLF-like MARVEL transmembrane domain containing 7
increases expression
ISO
avobenzone results in increased expression of CMTM7 mRNA
CTD
PMID:31016361
NCBI chr 8:122,814,563...122,841,479
Ensembl chr 8:122,812,459...122,841,477
G
Cnpy3
canopy FGF signaling regulator 3
increases expression
ISO
avobenzone results in increased expression of CNPY3 mRNA
CTD
PMID:31016361
NCBI chr 9:16,543,715...16,558,441
Ensembl chr 9:16,543,688...16,558,456
G
Cnst
consortin, connexin sorting protein
increases expression
ISO
avobenzone results in increased expression of CNST mRNA
CTD
PMID:31016361
NCBI chr13:97,838,325...97,915,131
Ensembl chr13:97,838,361...97,913,082
G
Cox19
cytochrome c oxidase assembly factor COX19
decreases expression
ISO
avobenzone results in decreased expression of COX19 mRNA
CTD
PMID:31016361
NCBI chr12:17,395,624...17,405,103
Ensembl chr12:17,395,624...17,405,103
G
Crebrf
CREB3 regulatory factor
increases expression
ISO
avobenzone results in increased expression of CREBRF mRNA
CTD
PMID:31016361
NCBI chr10:16,693,846...16,753,162
Ensembl chr10:16,694,792...16,752,205
G
Creg2
cellular repressor of E1A-stimulated genes 2
increases expression
ISO
avobenzone results in increased expression of CREG2 mRNA
CTD
PMID:31016361
NCBI chr 9:46,328,088...46,402,237
Ensembl chr 9:46,360,061...46,401,911
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
avobenzone results in increased expression of CYP1A1 mRNA
CTD
PMID:31016361
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases expression
ISO
avobenzone results in decreased expression of CYP1B1 mRNA
CTD
PMID:31016361
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
G
Cyp4f1
cytochrome P450, family 4, subfamily f, polypeptide 1
decreases expression
ISO
avobenzone results in decreased expression of CYP4F12 mRNA
CTD
PMID:31016361
NCBI chr 7:15,179,472...15,191,113
Ensembl chr 7:15,179,467...15,190,796
G
Cyp4f40
cytochrome P450, family 4, subfamily f, polypeptide 40
increases expression
ISO
avobenzone results in increased expression of CYP4F11 mRNA
CTD
PMID:31016361
NCBI chr 7:14,865,941...14,880,084
Ensembl chr 7:14,865,941...14,880,084
G
Dbp
D-box binding PAR bZIP transcription factor
increases expression
ISO
avobenzone results in increased expression of DBP mRNA
CTD
PMID:31016361
NCBI chr 1:101,687,896...101,692,845
Ensembl chr 1:101,687,855...101,692,846
G
Dcbld2
discoidin, CUB and LCCL domain containing 2
increases expression
ISO
avobenzone results in increased expression of DCBLD2 mRNA
CTD
PMID:31016361
NCBI chr11:44,237,814...44,292,884
Ensembl chr11:44,241,111...44,292,884
G
Ddx54
DEAD-box helicase 54
increases expression
ISO
avobenzone results in increased expression of DDX54 mRNA
CTD
PMID:31016361
NCBI chr12:41,469,642...41,484,887
Ensembl chr12:41,470,557...41,485,122
G
Ddx59
DEAD-box helicase 59
increases expression
ISO
avobenzone results in increased expression of DDX59 mRNA
CTD
PMID:31016361
NCBI chr13:53,299,872...53,324,824
Ensembl chr13:53,299,872...53,324,824
G
Decr2
2,4-dienoyl-CoA reductase 2
decreases expression
ISO
avobenzone results in decreased expression of DECR2 mRNA
CTD
PMID:31016361
NCBI chr10:15,451,850...15,460,227
Ensembl chr10:15,431,638...15,465,413
G
Dennd5b
DENN domain containing 5B
increases expression
ISO
avobenzone results in increased expression of DENND5B mRNA
CTD
PMID:31016361
NCBI chr 4:183,476,093...183,604,940
Ensembl chr 4:183,476,093...183,544,850
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
ISO
avobenzone results in decreased expression of DGAT2 mRNA
CTD
PMID:31016361
NCBI chr 1:164,113,459...164,143,818
Ensembl chr 1:164,113,459...164,143,818
G
Dhcr7
7-dehydrocholesterol reductase
increases expression
ISO
avobenzone results in increased expression of DHCR7 mRNA
CTD
PMID:31016361
NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
G
Dhrs9
dehydrogenase/reductase 9
decreases expression
ISO
avobenzone results in decreased expression of DHRS9 mRNA
CTD
PMID:31016361
NCBI chr 3:55,623,671...55,645,883
Ensembl chr 3:55,623,634...55,648,325
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
increases expression
ISO
avobenzone results in increased expression of DKK1 mRNA
CTD
PMID:31016361
NCBI chr 1:248,952,896...248,956,579
Ensembl chr 1:248,895,738...248,898,607 Ensembl chr 1:248,895,738...248,898,607
G
Dkk3
dickkopf WNT signaling pathway inhibitor 3
increases expression
ISO
avobenzone results in increased expression of DKK3 mRNA
CTD
PMID:31016361
NCBI chr 1:176,940,424...176,983,076
Ensembl chr 1:176,940,693...176,983,045
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
ISO
avobenzone results in increased expression of DNAJB9 mRNA
CTD
PMID:31016361
NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
G
Dnajc30
DnaJ heat shock protein family (Hsp40) member C30
decreases expression
ISO
avobenzone results in decreased expression of DNAJC30 mRNA
CTD
PMID:31016361
NCBI chr12:24,668,398...24,669,464
Ensembl chr12:24,668,398...24,669,464
G
Dok7
docking protein 7
increases expression
ISO
avobenzone results in increased expression of DOK7 mRNA
CTD
PMID:31016361
NCBI chr14:80,925,409...80,963,454
Ensembl chr14:80,926,654...80,958,478
G
Dsc1
desmocollin 1
decreases expression
ISO
avobenzone results in decreased expression of DSC1 mRNA
CTD
PMID:31016361
NCBI chr18:11,877,918...11,906,828
Ensembl chr18:11,877,561...11,906,827
G
Dsg1
desmoglein 1
decreases expression
ISO
avobenzone results in decreased expression of DSG1 mRNA
CTD
PMID:31016361
NCBI chr18:12,008,301...12,040,337
Ensembl chr18:12,008,759...12,038,053
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
avobenzone results in increased expression of DUSP10 mRNA
CTD
PMID:31016361
NCBI chr13:104,284,660...104,321,455
Ensembl chr13:104,284,660...104,321,455
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
avobenzone results in increased expression of DUSP4 mRNA
CTD
PMID:31016361
NCBI chr16:61,080,767...61,090,973
Ensembl chr16:61,078,175...61,091,169
G
Ebp
EBP, cholestenol delta-isomerase
increases expression
ISO
avobenzone results in increased expression of EBP mRNA
CTD
PMID:31016361
NCBI chr X:15,049,394...15,055,782
Ensembl chr X:15,049,462...15,055,781
G
Echdc3
enoyl CoA hydratase domain containing 3
increases expression
ISO
avobenzone results in increased expression of ECHDC3 mRNA
CTD
PMID:31016361
NCBI chr17:76,002,304...76,022,813
Ensembl chr17:76,002,275...76,022,813
G
Ecm2
extracellular matrix protein 2
decreases expression
ISO
avobenzone results in decreased expression of ECM2 mRNA
CTD
PMID:31016361
NCBI chr17:15,533,760...15,566,403
Ensembl chr17:15,533,972...15,566,332
G
Egfr
epidermal growth factor receptor
increases expression
ISO
avobenzone results in increased expression of EGFR mRNA
CTD
PMID:31016361
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Eid2
EP300 interacting inhibitor of differentiation 2
decreases expression
ISO
avobenzone results in decreased expression of EID2 mRNA
CTD
PMID:31016361
NCBI chr 1:85,515,610...85,517,516
Ensembl chr 1:85,516,653...85,517,360
G
Eif2ak4
eukaryotic translation initiation factor 2 alpha kinase 4
increases expression
ISO
avobenzone results in increased expression of EIF2AK4 mRNA
CTD
PMID:31016361
NCBI chr 3:110,159,624...110,245,382
Ensembl chr 3:110,159,708...110,249,217
G
Elp1
elongator acetyltransferase complex subunit 1
increases expression
ISO
avobenzone results in increased expression of ELP1 mRNA
CTD
PMID:31016361
NCBI chr 5:73,503,406...73,552,798
Ensembl chr 5:73,503,407...73,552,798
G
Emp3
epithelial membrane protein 3
increases expression
ISO
avobenzone results in increased expression of EMP3 mRNA
CTD
PMID:31016361
NCBI chr 1:101,900,731...101,903,948
Ensembl chr 1:101,900,733...101,903,910
G
Epha4
Eph receptor A4
decreases expression
ISO
avobenzone results in decreased expression of EPHA4 mRNA
CTD
PMID:31016361
NCBI chr 9:83,111,222...83,253,486
Ensembl chr 9:83,111,222...83,253,458
G
Ephx3
epoxide hydrolase 3
decreases expression
ISO
avobenzone results in decreased expression of EPHX3 mRNA
CTD
PMID:31016361
NCBI chr 7:14,212,470...14,217,778
Ensembl chr 7:14,212,470...14,217,778
G
Epm2aip1
EPM2A interacting protein 1
decreases expression
ISO
avobenzone results in decreased expression of EPM2AIP1 mRNA
CTD
PMID:31016361
NCBI chr 8:119,524,039...119,531,387
Ensembl chr 8:119,524,039...119,531,387
G
Eri1
exoribonuclease 1
increases expression
ISO
avobenzone results in increased expression of ERI1 mRNA
CTD
PMID:31016361
NCBI chr16:60,307,148...60,327,237
Ensembl chr16:60,307,148...60,327,236
G
Esr1
estrogen receptor 1
multiple interactions
ISO
avobenzone binds to and results in increased activity of ESR1 protein
CTD
PMID:15537743
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Etv4
ETS variant transcription factor 4
increases expression
ISO
avobenzone results in increased expression of ETV4 mRNA
CTD
PMID:31016361
NCBI chr10:89,685,058...89,700,300
Ensembl chr10:89,685,058...89,700,283
G
F2r
coagulation factor II (thrombin) receptor
increases expression
ISO
avobenzone results in increased expression of F2R mRNA
CTD
PMID:31016361
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
G
Fabp4
fatty acid binding protein 4
multiple interactions
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]
CTD
PMID:31016361 PMID:32407875
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
G
Fam185a
family with sequence similarity 185, member A
decreases expression
ISO
avobenzone results in decreased expression of FAM185A mRNA
CTD
PMID:31016361
NCBI chr 4:10,213,679...10,269,999
G
Fam217b
family with sequence similarity 217, member B
increases expression
ISO
avobenzone results in increased expression of FAM217B mRNA
CTD
PMID:31016361
NCBI chr 3:173,953,752...173,961,615
Ensembl chr 3:173,953,869...173,963,629
G
Fam241a
family with sequence similarity 241 member A
decreases expression
ISO
avobenzone results in decreased expression of FAM241A mRNA
CTD
PMID:31016361
NCBI chr 2:232,214,331...232,245,319
Ensembl chr 2:232,214,331...232,245,319
G
Fam3c
FAM3 metabolism regulating signaling molecule C
increases expression
ISO
avobenzone results in increased expression of FAM3C mRNA
CTD
PMID:31016361
NCBI chr 4:49,388,962...49,439,892
Ensembl chr 4:49,387,989...49,439,867
G
Fam43a
family with sequence similarity 43, member A
decreases expression
ISO
avobenzone results in decreased expression of FAM43A mRNA
CTD
PMID:31016361
NCBI chr11:73,676,601...73,679,003
Ensembl chr11:73,676,601...73,678,984
G
Fanci
FA complementation group I
increases expression
ISO
avobenzone results in increased expression of FANCI mRNA
CTD
PMID:31016361
NCBI chr 1:141,116,565...141,172,997
Ensembl chr 1:141,120,166...141,172,483
G
Fasn
fatty acid synthase
increases expression
ISO
avobenzone results in increased expression of FASN mRNA
CTD
PMID:31016361
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
G
Fbn2
fibrillin 2
increases expression
ISO
avobenzone results in increased expression of FBN2 mRNA
CTD
PMID:31016361
NCBI chr18:53,068,495...53,272,254
Ensembl chr18:53,068,495...53,181,503
G
Fbxl20
F-box and leucine-rich repeat protein 20
increases expression
ISO
avobenzone results in increased expression of FBXL20 mRNA
CTD
PMID:31016361
NCBI chr10:86,036,745...86,099,699
Ensembl chr10:86,043,235...86,098,694
G
Fbxo32
F-box protein 32
increases expression
ISO
avobenzone results in increased expression of FBXO32 mRNA
CTD
PMID:31016361
NCBI chr 7:98,065,664...98,098,071
Ensembl chr 7:98,063,735...98,098,268
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
ISO
avobenzone results in increased expression of FDFT1 mRNA
CTD
PMID:31016361
NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
G
Fdps
farnesyl diphosphate synthase
increases expression
ISO
avobenzone results in increased expression of FDPS mRNA
CTD
PMID:31016361
NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
G
Fgd6
FYVE, RhoGEF and PH domain containing 6
increases expression
ISO
avobenzone results in increased expression of FGD6 mRNA
CTD
PMID:31016361
NCBI chr 7:34,951,878...35,063,006
Ensembl chr 7:34,952,011...35,063,929
G
Fibin
fin bud initiation factor homolog
decreases expression
ISO
avobenzone results in decreased expression of FIBIN mRNA
CTD
PMID:31016361
NCBI chr 3:101,545,207...101,547,478
Ensembl chr 3:101,545,208...101,547,478
G
Filip1l
filamin A interacting protein 1-like
decreases expression
ISO
avobenzone results in decreased expression of FILIP1L mRNA
CTD
PMID:31016361
NCBI chr11:45,039,488...45,275,141
Ensembl chr11:45,039,461...45,124,423
G
Flg
filaggrin
decreases expression
ISO
avobenzone results in decreased expression of FLG mRNA
CTD
PMID:31016361
NCBI chr 2:193,565,401...193,574,297
G
Flg2
filaggrin family member 2
decreases expression
ISO
avobenzone results in decreased expression of FLG2 mRNA
CTD
PMID:31016361
NCBI chr 2:193,480,880...193,485,463
Ensembl chr 2:193,483,793...193,485,313
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
avobenzone results in decreased expression of FOS mRNA
CTD
PMID:31016361
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Foxk1
forkhead box K1
increases expression
ISO
avobenzone results in increased expression of FOXK1 mRNA
CTD
PMID:31016361
NCBI chr12:14,183,436...14,244,634
Ensembl chr12:14,180,029...14,244,316
G
Foxp2
forkhead box P2
decreases expression
ISO
avobenzone results in decreased expression of FOXP2 mRNA
CTD
PMID:31016361
NCBI chr 4:41,364,441...41,944,685
Ensembl chr 4:41,364,441...41,942,023
G
Fry
FRY microtubule binding protein
decreases expression
ISO
avobenzone results in decreased expression of FRY mRNA
CTD
PMID:31016361
NCBI chr12:5,573,729...5,822,874
Ensembl chr12:5,573,729...5,822,874
G
Fzd2
frizzled class receptor 2
increases expression
ISO
avobenzone results in increased expression of FZD2 mRNA
CTD
PMID:31016361
NCBI chr10:90,550,147...90,552,057
Ensembl chr10:90,550,147...90,552,057
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression
ISO
avobenzone results in increased expression of GABARAPL1 mRNA
CTD
PMID:31016361
NCBI chr 4:163,293,724...163,302,866
Ensembl chr 4:163,293,724...163,302,858
G
Gask1b
golgi associated kinase 1B
increases expression
ISO
avobenzone results in increased expression of GASK1B mRNA
CTD
PMID:31016361
NCBI chr 2:178,678,946...178,751,459
Ensembl chr 2:178,679,041...178,750,668
G
Gcat
glycine C-acetyltransferase
increases expression
ISO
avobenzone results in increased expression of GCAT mRNA
CTD
PMID:31016361
NCBI chr 7:120,263,068...120,269,365
Ensembl chr 7:120,263,054...120,269,451
G
Gchfr
GTP cyclohydrolase I feedback regulator
increases expression
ISO
avobenzone results in increased expression of GCHFR mRNA
CTD
PMID:31016361
NCBI chr 3:110,975,923...110,979,957
Ensembl chr 3:110,975,923...110,979,957
G
Gdap1
ganglioside-induced differentiation-associated-protein 1
decreases expression
ISO
avobenzone results in decreased expression of GDAP1 mRNA
CTD
PMID:31016361
NCBI chr 5:1,328,963...1,347,946
Ensembl chr 5:1,328,913...1,347,921
G
Gen1
GEN1 Holliday junction 5' flap endonuclease
decreases expression
ISO
avobenzone results in decreased expression of GEN1 mRNA
CTD
PMID:31016361
NCBI chr 6:36,910,064...36,940,868
Ensembl chr 6:36,910,675...36,940,868
G
Ggact
gamma-glutamylamine cyclotransferase
decreases expression
ISO
avobenzone results in decreased expression of GGACT mRNA
CTD
PMID:31016361
NCBI chr15:109,307,683...109,336,779
Ensembl chr15:109,307,904...109,316,953
G
Gjb6
gap junction protein, beta 6
decreases expression
ISO
avobenzone results in decreased expression of GJB6 mRNA
CTD
PMID:31016361
NCBI chr15:37,400,888...37,411,656
Ensembl chr15:37,400,889...37,410,848
G
Glul
glutamate-ammonia ligase
increases expression
ISO
avobenzone results in increased expression of GLUL mRNA
CTD
PMID:31016361
NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
G
Gne
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
increases expression
ISO
avobenzone results in increased expression of GNE mRNA
CTD
PMID:31016361
NCBI chr 5:59,511,738...59,553,421
Ensembl chr 5:59,512,872...59,553,416
G
Gpnmb
glycoprotein nmb
increases expression
ISO
avobenzone results in increased expression of GPNMB mRNA
CTD
PMID:31016361
NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683
G
Gpr1
G protein-coupled receptor 1
decreases expression
ISO
avobenzone results in decreased expression of GPR1 mRNA
CTD
PMID:31016361
NCBI chr 9:69,958,607...69,991,410
Ensembl chr 9:69,959,025...69,960,086
G
Gsk3b
glycogen synthase kinase 3 beta
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of GSK3B protein
CTD
PMID:29981360
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
G
Gspt2
G1 to S phase transition 2
decreases expression
ISO
avobenzone results in decreased expression of GSPT2 mRNA
CTD
PMID:31016361
NCBI chr X:63,959,131...63,961,652
Ensembl chr X:63,954,727...63,961,613
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
avobenzone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
Gtf3c2
general transcription factor IIIC subunit 2
increases expression
ISO
avobenzone results in increased expression of GTF3C2 mRNA
CTD
PMID:31016361
NCBI chr 6:26,560,601...26,584,533
Ensembl chr 6:26,560,601...26,584,535
G
Habp4
hyaluronan binding protein 4
increases expression
ISO
avobenzone results in increased expression of HABP4 mRNA
CTD
PMID:31016361
NCBI chr17:1,679,561...1,702,245
Ensembl chr17:1,679,627...1,701,623
G
Harbi1
harbinger transposase derived 1
decreases expression
ISO
avobenzone results in decreased expression of HARBI1 mRNA
CTD
PMID:31016361
NCBI chr 3:80,614,886...80,624,213
Ensembl chr 3:80,614,937...80,624,205
G
Heg1
heart development protein with EGF-like domains 1
increases expression
ISO
avobenzone results in increased expression of HEG1 mRNA
CTD
PMID:31016361
NCBI chr11:70,234,248...70,322,966
Ensembl chr11:70,236,888...70,322,690
G
Henmt1
HEN methyltransferase 1
decreases expression
ISO
avobenzone results in decreased expression of HENMT1 mRNA
CTD
PMID:31016361
NCBI chr 2:211,740,571...211,753,718
G
Hes5
hes family bHLH transcription factor 5
decreases expression
ISO
avobenzone results in decreased expression of HES5 mRNA
CTD
PMID:31016361
NCBI chr 5:172,364,421...172,365,188
Ensembl chr 5:172,364,421...172,365,188
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
avobenzone results in increased expression of HMGCR mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
avobenzone results in increased expression of HMGCS1 mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
G
Homez
homeobox and leucine zipper encoding
decreases expression
ISO
avobenzone results in decreased expression of HOMEZ mRNA
CTD
PMID:31016361
NCBI chr15:33,510,454...33,528,018
Ensembl chr15:33,510,458...33,527,031
G
Hp1bp3
heterochromatin protein 1, binding protein 3
increases expression
ISO
avobenzone results in increased expression of HP1BP3 mRNA
CTD
PMID:31016361
NCBI chr 5:156,581,732...156,609,059
Ensembl chr 5:156,581,732...156,609,059
G
Hs3st6
heparan sulfate-glucosamine 3-sulfotransferase 6
decreases expression
ISO
avobenzone results in decreased expression of HS3ST6 mRNA
CTD
PMID:31016361
NCBI chr10:14,122,856...14,128,984
Ensembl chr10:14,122,878...14,128,983
G
Hsd17b14
hydroxysteroid (17-beta) dehydrogenase 14
increases expression
ISO
avobenzone results in increased expression of HSD17B14 mRNA
CTD
PMID:31016361
NCBI chr 1:101,541,266...101,551,059
Ensembl chr 1:101,541,266...101,551,059
G
Id1
inhibitor of DNA binding 1, HLH protein
decreases expression
ISO
avobenzone results in decreased expression of ID1 mRNA
CTD
PMID:31016361
NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
G
Id4
inhibitor of DNA binding 4, HLH protein
decreases expression
ISO
avobenzone results in decreased expression of ID4 mRNA
CTD
PMID:31016361
NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
ISO
avobenzone results in increased expression of IDI1 mRNA
CTD
PMID:31016361
NCBI chr17:57,976,266...57,984,036
Ensembl chr17:57,976,268...57,984,036
G
Idnk
Idnk, gluconokinase
decreases expression
ISO
avobenzone results in decreased expression of IDNK mRNA
CTD
PMID:31016361
NCBI chr17:6,885,323...6,892,603
Ensembl chr17:6,885,221...6,892,497
G
Ifi27
interferon, alpha-inducible protein 27
multiple interactions increases expression
ISO
avobenzone inhibits the reaction [IFI27 mRNA results in increased expression of BTBD7 mRNA]; IFI27 mRNA inhibits the reaction [avobenzone results in decreased expression of BTBD7 mRNA] avobenzone results in increased expression of IFI27 mRNA
CTD
PMID:29981360
NCBI chr 6:127,327,959...127,334,430
Ensembl chr 6:127,327,959...127,334,428
G
Ifi27l2b
interferon, alpha-inducible protein 27 like 2B
increases expression
ISO
avobenzone results in increased expression of IFI27L2 mRNA
CTD
PMID:29981360
NCBI chr 6:127,336,305...127,337,791
Ensembl chr 6:127,336,305...127,337,791
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
ISO
avobenzone results in decreased expression of IFIT3 mRNA
CTD
PMID:31016361
NCBI chr 1:252,906,234...252,911,377
Ensembl chr 1:252,906,234...252,911,382
G
Igfbp7
insulin-like growth factor binding protein 7
increases expression
ISO
avobenzone results in increased expression of IGFBP7 mRNA
CTD
PMID:31016361
NCBI chr14:33,010,300...33,070,193
Ensembl chr14:33,010,300...33,070,190
G
Ikbip
IKBKB interacting protein
increases expression
ISO
avobenzone results in increased expression of IKBIP mRNA
CTD
PMID:31016361
NCBI chr 7:31,784,390...31,803,200
Ensembl chr 7:31,784,438...31,803,194
G
Il18r1
interleukin 18 receptor 1
decreases expression
ISO
avobenzone results in decreased expression of IL18R1 mRNA
CTD
PMID:31016361
NCBI chr 9:47,184,404...47,217,403
Ensembl chr 9:47,185,443...47,219,175
G
Il33
interleukin 33
increases expression
ISO
avobenzone results in increased expression of IL33 mRNA
CTD
PMID:31016361
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
avobenzone results in decreased expression of IMPA2 mRNA
CTD
PMID:31016361
NCBI chr18:63,016,577...63,050,123
Ensembl chr18:63,016,577...63,047,781
G
Inf2
inverted formin 2
increases expression
ISO
avobenzone results in increased expression of INF2 mRNA
CTD
PMID:31016361
NCBI chr 6:137,162,593...137,180,198
Ensembl chr 6:137,164,535...137,177,622
G
Ing1
inhibitor of growth family, member 1
increases expression
ISO
avobenzone results in increased expression of ING1 mRNA
CTD
PMID:31016361
NCBI chr16:83,277,055...83,278,120
Ensembl chr16:83,276,273...83,278,119
G
Ins2
insulin 2
multiple interactions
ISO
[avobenzone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARA mRNA; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of TNFRSF11B mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; T 0070907 affects the reaction [avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]
CTD
PMID:31016361 PMID:32407875
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
G
Insig1
insulin induced gene 1
increases expression
ISO
avobenzone results in increased expression of INSIG1 mRNA
CTD
PMID:31016361
NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
G
Irs2
insulin receptor substrate 2
increases expression
ISO
avobenzone results in increased expression of IRS2 mRNA
CTD
PMID:31016361
NCBI chr16:83,824,515...83,848,569
Ensembl chr16:83,824,430...83,848,684
G
Irx3
iroquois homeobox 3
decreases expression
ISO
avobenzone results in decreased expression of IRX3 mRNA
CTD
PMID:31016361
NCBI chr19:15,838,714...15,842,135
Ensembl chr19:15,838,714...15,840,990
G
Itpkb
inositol-trisphosphate 3-kinase B
increases expression
ISO
avobenzone results in increased expression of ITPKB mRNA
CTD
PMID:31016361
NCBI chr13:98,615,287...98,710,426
Ensembl chr13:98,615,287...98,708,149
G
Jmy
junction mediating and regulatory protein, p53 cofactor
increases expression
ISO
avobenzone results in increased expression of JMY mRNA
CTD
PMID:31016361
NCBI chr 2:23,026,506...23,097,702
Ensembl chr 2:23,042,189...23,097,610
G
Jpx
JPX transcript, XIST activator
decreases expression
ISO
avobenzone results in decreased expression of JPX mRNA
CTD
PMID:31016361
NCBI chr X:74,499,442...74,518,419
G
Jrk
Jrk helix-turn-helix protein
increases expression
ISO
avobenzone results in increased expression of JRK mRNA
CTD
PMID:31016361
NCBI chr 7:115,941,788...115,946,471
Ensembl chr 7:115,942,743...115,946,425
G
Jrkl
JRK-like
decreases expression
ISO
avobenzone results in decreased expression of JRKL mRNA
CTD
PMID:31016361
NCBI chr 8:11,884,903...11,887,799
Ensembl chr 8:11,884,903...11,887,799
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
decreases expression
ISO
avobenzone results in decreased expression of KCNJ5 mRNA
CTD
PMID:31016361
NCBI chr 8:33,435,493...33,463,410
Ensembl chr 8:33,433,905...33,463,467
G
Kctd11
potassium channel tetramerization domain containing 11
decreases expression
ISO
avobenzone results in decreased expression of KCTD11 mRNA
CTD
PMID:31016361
NCBI chr10:56,489,552...56,491,715
Ensembl chr10:56,489,552...56,491,715
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
increases expression
ISO
avobenzone results in increased expression of KDELR3 mRNA
CTD
PMID:31016361
NCBI chr 7:120,749,680...120,760,163
Ensembl chr 7:120,749,752...120,760,160
G
Klf10
Kruppel-like factor 10
decreases expression
ISO
avobenzone results in decreased expression of KLF10 mRNA
CTD
PMID:31016361
NCBI chr 7:77,156,010...77,162,096
Ensembl chr 7:77,156,006...77,162,148
G
Klf16
Kruppel-like factor 16
increases expression
ISO
avobenzone results in increased expression of KLF16 mRNA
CTD
PMID:31016361
NCBI chr 7:12,006,710...12,016,529
Ensembl chr 7:12,006,710...12,016,524
G
Klhl24
kelch-like family member 24
increases expression
ISO
avobenzone results in increased expression of KLHL24 mRNA
CTD
PMID:31016361
NCBI chr11:84,613,101...84,643,674
Ensembl chr11:84,615,760...84,633,504
G
Klhl9
kelch-like family member 9
decreases expression
ISO
avobenzone results in decreased expression of KLHL9 mRNA
CTD
PMID:31016361
NCBI chr 5:107,323,258...107,327,442
Ensembl chr 5:107,323,258...107,327,442
G
Kmt2d
lysine methyltransferase 2D
increases expression
ISO
avobenzone results in increased expression of KMT2D mRNA
CTD
PMID:31016361
NCBI chr 7:140,507,137...140,542,479
Ensembl chr 7:140,489,492...140,546,908
G
Krcc1
lysine-rich coiled-coil 1
decreases expression
ISO
avobenzone results in decreased expression of KRCC1 mRNA
CTD
PMID:31016361
NCBI chr 4:99,133,735...99,148,236
Ensembl chr 4:99,133,842...99,146,827
G
Krt1
keratin 1
decreases expression
ISO
avobenzone results in decreased expression of KRT1 mRNA
CTD
PMID:31016361
NCBI chr 7:143,448,318...143,453,544
Ensembl chr 7:143,448,318...143,453,544
G
Krtap8-1
keratin associated protein 8-1
decreases expression
ISO
avobenzone results in decreased expression of KRTAP8-1 mRNA
CTD
PMID:31016361
NCBI chr11:29,618,650...29,618,941
Ensembl chr11:29,618,672...29,618,857
G
Kyat1
kynurenine aminotransferase 1
increases expression
ISO
avobenzone results in increased expression of KYAT1 mRNA
CTD
PMID:31016361
NCBI chr 3:8,752,289...8,785,617
Ensembl chr 3:8,752,625...8,766,433
G
L3mbtl1
L3MBTL histone methyl-lysine binding protein 1
increases expression
ISO
avobenzone results in increased expression of L3MBTL1 mRNA
CTD
PMID:31016361
NCBI chr 3:159,316,580...159,348,914
Ensembl chr 3:159,321,310...159,347,631
G
Lactb
lactamase, beta
increases expression
ISO
avobenzone results in increased expression of LACTB mRNA
CTD
PMID:31016361
NCBI chr 8:72,750,174...72,766,307
Ensembl chr 8:72,750,171...72,766,389
G
Lamp3
lysosomal-associated membrane protein 3
decreases expression
ISO
avobenzone results in decreased expression of LAMP3 mRNA
CTD
PMID:31016361
NCBI chr11:84,930,965...85,000,694
Ensembl chr11:84,972,132...85,000,681
G
Lcmt2
leucine carboxyl methyltransferase 2
decreases expression
ISO
avobenzone results in decreased expression of LCMT2 mRNA
CTD
PMID:31016361
NCBI chr 3:113,089,646...113,091,770
Ensembl chr 3:113,089,647...113,091,770
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
avobenzone results in increased expression of LDLR mRNA
CTD
PMID:31016361
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
G
Lima1
LIM domain and actin binding 1
increases expression
ISO
avobenzone results in increased expression of LIMA1 mRNA
CTD
PMID:31016361
NCBI chr 7:141,428,113...141,528,447
Ensembl chr 7:141,428,063...141,528,397
G
Lix1l
limb and CNS expressed 1 like
increases expression
ISO
avobenzone results in increased expression of LIX1L mRNA
CTD
PMID:31016361
NCBI chr 2:198,726,110...198,751,987
Ensembl chr 2:198,726,118...198,751,985
G
Lmln
leishmanolysin like peptidase
decreases expression
ISO
avobenzone results in decreased expression of LMLN mRNA
CTD
PMID:31016361
NCBI chr11:70,895,141...70,963,121
Ensembl chr11:70,897,052...70,961,358
G
Lnx1
ligand of numb-protein X 1
increases expression
ISO
avobenzone results in increased expression of LNX1 mRNA
CTD
PMID:31016361
NCBI chr14:36,047,136...36,149,740
Ensembl chr14:36,047,144...36,149,740
G
LOC100125364
hypothetical protein LOC100125364
decreases expression
ISO
avobenzone results in decreased expression of C6ORF120 mRNA
CTD
PMID:31016361
NCBI chr 1:56,949,712...56,952,436
Ensembl chr 1:56,949,712...56,952,431
G
LOC100912373
uncharacterized LOC100912373
increases expression
ISO
avobenzone results in increased expression of C8ORF88 mRNA
CTD
PMID:31016361
NCBI chr 5:28,480,029...28,505,430
Ensembl chr 5:28,480,023...28,505,432
G
LOC102552284
zinc finger protein 420-like
decreases expression
ISO
avobenzone results in decreased expression of ZNF765 mRNA
CTD
PMID:31016361
NCBI chr 1:64,721,939...64,749,676
G
LOC688765
hypothetical protein LOC688765
decreases expression
ISO
avobenzone results in decreased expression of C8ORF48 mRNA
CTD
PMID:31016361
NCBI chr16:58,729,775...58,731,673
G
Loricrin
loricrin cornified envelope precursor protein
decreases expression
ISO
avobenzone results in decreased expression of LORICRIN mRNA
CTD
PMID:31016361
NCBI chr 2:191,984,455...191,990,713
Ensembl chr 2:191,984,773...191,986,170
G
Lpcat4
lysophosphatidylcholine acyltransferase 4
increases expression
ISO
avobenzone results in increased expression of LPCAT4 mRNA
CTD
PMID:31016361
NCBI chr 3:103,725,762...103,733,888
Ensembl chr 3:103,726,238...103,733,354
G
Lpin1
lipin 1
increases expression
ISO
avobenzone results in increased expression of LPIN1 mRNA
CTD
PMID:31016361
NCBI chr 6:41,796,214...41,905,149
Ensembl chr 6:41,799,749...41,870,046
G
Lrrc8d
leucine rich repeat containing 8 VRAC subunit D
decreases expression
ISO
avobenzone results in decreased expression of LRRC8D mRNA
CTD
PMID:31016361
NCBI chr14:5,085,606...5,194,808
Ensembl chr14:5,086,054...5,101,177
G
Lss
lanosterol synthase
increases expression
ISO
avobenzone results in increased expression of LSS mRNA
CTD
PMID:31016361
NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497
G
Luc7l
LUC7-like
increases expression
ISO
avobenzone results in increased expression of LUC7L mRNA
CTD
PMID:31016361
NCBI chr10:15,538,878...15,572,651
Ensembl chr10:15,538,872...15,568,638
G
Ly9
lymphocyte antigen 9
increases expression
ISO
avobenzone results in increased expression of LY9 mRNA
CTD
PMID:31016361
NCBI chr13:90,002,779...90,022,346
Ensembl chr13:90,002,783...90,022,269
G
Lynx1
Ly6/neurotoxin 1
increases expression
ISO
avobenzone results in increased expression of LYNX1 mRNA
CTD
PMID:31016361
NCBI chr 7:115,982,877...115,988,121
Ensembl chr 7:115,982,876...115,988,090
G
Lypd6b
LY6/PLAUR domain containing 6B
decreases expression
ISO
avobenzone results in decreased expression of LYPD6B mRNA
CTD
PMID:31016361
NCBI chr 3:35,271,785...35,437,296
Ensembl chr 3:35,271,786...35,437,296
G
Mab21l3
mab-21 like 3
decreases expression
ISO
avobenzone results in decreased expression of MAB21L3 mRNA
CTD
PMID:31016361
NCBI chr 2:204,231,936...204,269,235
Ensembl chr 2:204,231,685...204,254,699
G
Mafb
MAF bZIP transcription factor B
decreases expression
ISO
avobenzone results in decreased expression of MAFB mRNA
CTD
PMID:31016361
NCBI chr 3:156,338,993...156,340,913
Ensembl chr 3:156,339,004...156,340,913
G
Maged2
MAGE family member D2
increases expression
ISO
avobenzone results in increased expression of MAGED2 mRNA
CTD
PMID:31016361
NCBI chr 5:33,174,539...33,182,715
Ensembl chr 5:33,174,542...33,182,715
G
Magee1
MAGE family member E1
increases expression
ISO
avobenzone results in increased expression of MAGEE1 mRNA
CTD
PMID:31016361
NCBI chr X:76,083,553...76,087,100
Ensembl chr X:76,083,549...76,087,117
G
Maml3
mastermind-like transcriptional coactivator 3
decreases expression
ISO
avobenzone results in decreased expression of MAML3 mRNA
CTD
PMID:31016361
NCBI chr 2:140,734,138...141,276,886
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of MAPK1 protein
CTD
PMID:29981360
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of MAPK3 protein
CTD
PMID:29981360
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mblac2
metallo-beta-lactamase domain containing 2
decreases expression
ISO
avobenzone results in decreased expression of MBLAC2 mRNA
CTD
PMID:31016361
NCBI chr 2:9,578,501...9,621,297
Ensembl chr 2:9,578,345...9,623,513
G
Mcm4
minichromosome maintenance complex component 4
increases expression
ISO
avobenzone results in increased expression of MCM4 mRNA
CTD
PMID:31016361
NCBI chr11:89,511,191...89,524,892
Ensembl chr11:89,511,191...89,524,892
G
Mcm5
minichromosome maintenance complex component 5
increases expression
ISO
avobenzone results in increased expression of MCM5 mRNA
CTD
PMID:31016361
NCBI chr19:14,523,482...14,561,281
Ensembl chr19:14,523,554...14,561,278
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
avobenzone results in increased expression of MDM2 mRNA
CTD
PMID:31016361
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
G
Mettl21a
methyltransferase like 21A
increases expression
ISO
avobenzone results in increased expression of METTL21A mRNA
CTD
PMID:31016361
NCBI chr 9:71,304,138...71,314,015
Ensembl chr 9:71,304,427...71,313,940
G
Mfap3l
microfibril associated protein 3 like
decreases expression
ISO
avobenzone results in decreased expression of MFAP3L mRNA
CTD
PMID:31016361
NCBI chr16:32,734,059...32,777,091
Ensembl chr16:32,738,265...32,753,278
G
Mib1
MIB E3 ubiquitin protein ligase 1
increases expression
ISO
avobenzone results in increased expression of MIB1 mRNA
CTD
PMID:31016361
NCBI chr18:1,970,914...2,094,920
Ensembl chr18:1,970,914...2,094,920
G
Micall2
MICAL-like 2
increases expression
ISO
avobenzone results in increased expression of MICALL2 mRNA
CTD
PMID:31016361
NCBI chr12:16,988,013...17,016,794
Ensembl chr12:16,988,136...17,016,791
G
Micb
MHC class I polypeptide-related sequence B
increases expression
ISO
avobenzone results in increased expression of MICB mRNA
CTD
PMID:31016361
NCBI chr 1:79,754,587...79,772,092
Ensembl chr 1:79,754,587...79,772,092
G
Mill1
MHC I like leukocyte 1
increases expression
ISO
avobenzone results in increased expression of MICA mRNA
CTD
PMID:31016361
NCBI chr 1:79,631,266...79,657,943
Ensembl chr 1:79,631,668...79,657,941
G
Mmp3
matrix metallopeptidase 3
decreases expression
ISO
avobenzone results in decreased expression of MMP3 mRNA
CTD
PMID:31016361
NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
G
Mnd1
meiotic nuclear divisions 1
increases expression
ISO
avobenzone results in increased expression of MND1 mRNA
CTD
PMID:31016361
NCBI chr 2:183,073,029...183,140,768
Ensembl chr 2:183,073,187...183,128,932
G
Mocs3
molybdenum cofactor synthesis 3
decreases expression
ISO
avobenzone results in decreased expression of MOCS3 mRNA
CTD
PMID:31016361
NCBI chr 3:164,986,421...164,988,381
Ensembl chr 3:164,986,421...164,988,369
G
Morf4l1
mortality factor 4 like 1
increases expression
ISO
avobenzone results in increased expression of MORF4L1 mRNA
CTD
PMID:31016361
NCBI chr 8:97,473,454...97,494,974
Ensembl chr 8:97,474,092...97,494,834
G
Mrpl39
mitochondrial ribosomal protein L39
increases expression
ISO
avobenzone results in increased expression of MRPL39 mRNA
CTD
PMID:31016361
NCBI chr11:24,181,605...24,200,022
Ensembl chr11:24,181,658...24,199,968
G
Msantd3
Myb/SANT DNA binding domain containing 3
increases expression
ISO
avobenzone results in increased expression of MSANTD3 mRNA
CTD
PMID:31016361
NCBI chr 5:64,282,351...64,308,606
Ensembl chr 5:64,282,351...64,306,860
G
Msto1
misato mitochondrial distribution and morphology regulator 1
decreases expression
ISO
avobenzone results in decreased expression of MSTO1 mRNA
CTD
PMID:31016361
NCBI chr 2:188,212,211...188,216,482
Ensembl chr 2:188,212,211...188,216,482
G
Mt2A
metallothionein 2A
increases expression
ISO
avobenzone results in increased expression of MT2A mRNA
CTD
PMID:31016361
NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
G
Muc15
mucin 15, cell surface associated
decreases expression
ISO
avobenzone results in decreased expression of MUC15 mRNA
CTD
PMID:31016361
NCBI chr 3:101,895,363...101,912,979
Ensembl chr 3:101,899,068...101,912,919
G
Mvd
mevalonate diphosphate decarboxylase
increases expression
ISO
avobenzone results in increased expression of MVD mRNA
CTD
PMID:31016361
NCBI chr19:55,258,910...55,268,933
Ensembl chr19:55,258,905...55,268,951
G
Myo3b
myosin IIIB
increases expression
ISO
avobenzone results in increased expression of MYO3B mRNA
CTD
PMID:31016361
NCBI chr 3:56,355,433...56,717,740
Ensembl chr 3:56,355,431...56,584,547
G
N4bp2l1
NEDD4 binding protein 2-like 1
increases expression
ISO
avobenzone results in increased expression of N4BP2L1 mRNA
CTD
PMID:31016361
NCBI chr12:546,759...576,744
Ensembl chr12:546,760...576,746
G
Ncoa5
nuclear receptor coactivator 5
decreases expression
ISO
avobenzone results in decreased expression of NCOA5 mRNA
CTD
PMID:31016361
NCBI chr 3:161,465,733...161,498,951
Ensembl chr 3:161,465,743...161,498,951
G
Ndufa4l2
NDUFA4, mitochondrial complex associated like 2
decreases expression
ISO
avobenzone results in decreased expression of NDUFA4L2 mRNA
CTD
PMID:31016361
NCBI chr 7:70,821,904...70,824,085
Ensembl chr 7:70,821,957...70,824,085
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
decreases expression
ISO
avobenzone results in decreased expression of NEDD4 mRNA
CTD
PMID:31016361
NCBI chr 8:79,323,408...79,408,842
Ensembl chr 8:79,323,408...79,408,833
G
Nhlrc2
NHL repeat containing 2
increases expression
ISO
avobenzone results in increased expression of NHLRC2 mRNA
CTD
PMID:31016361
NCBI chr 1:277,355,619...277,415,940
Ensembl chr 1:277,355,619...277,415,907
G
Nipal3
NIPA-like domain containing 3
increases expression
ISO
avobenzone results in increased expression of NIPAL3 mRNA
CTD
PMID:31016361
NCBI chr 5:153,808,169...153,843,961
Ensembl chr 5:153,807,955...153,840,178
G
Nkpd1
NTPase, KAP family P-loop domain containing 1
decreases expression
ISO
avobenzone results in decreased expression of NKPD1 mRNA
CTD
PMID:31016361
NCBI chr 1:80,424,507...80,434,137
Ensembl chr 1:80,426,918...80,432,875
G
Noct
nocturnin
increases expression
ISO
avobenzone results in increased expression of NOCT mRNA
CTD
PMID:31016361
NCBI chr 2:140,286,661...140,306,869
Ensembl chr 2:140,286,661...140,306,869
G
Npas2
neuronal PAS domain protein 2
increases expression
ISO
avobenzone results in increased expression of NPAS2 mRNA
CTD
PMID:31016361
NCBI chr 9:45,901,262...46,081,880
Ensembl chr 9:45,901,741...46,081,880
G
Npepl1
aminopeptidase-like 1
decreases expression
ISO
avobenzone results in decreased expression of NPEPL1 mRNA
CTD
PMID:31016361
NCBI chr 3:172,195,115...172,207,685
Ensembl chr 3:172,195,844...172,207,685
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
avobenzone results in increased expression of NQO1 mRNA
CTD
PMID:31016361
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
ISO
avobenzone results in increased expression of NR1D2 mRNA
CTD
PMID:31016361
NCBI chr15:8,730,871...8,757,165
Ensembl chr15:8,730,871...8,757,165
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects binding
ISO
avobenzone binds to NR3C1 protein
CTD
PMID:28115641
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
G
Nub1
negative regulator of ubiquitin-like proteins 1
increases expression
ISO
avobenzone results in increased expression of NUB1 mRNA
CTD
PMID:31016361
NCBI chr 4:6,950,870...6,981,400
Ensembl chr 4:6,951,478...6,978,073
G
Nwd2
NACHT and WD repeat domain containing 2
decreases expression
ISO
avobenzone results in decreased expression of NWD2 mRNA
CTD
PMID:31016361
NCBI chr14:46,136,780...46,153,320
Ensembl chr14:46,136,786...46,153,212
G
Obsl1
obscurin like cytoskeletal adaptor 1
increases expression
ISO
avobenzone results in increased expression of OBSL1 mRNA
CTD
PMID:31016361
NCBI chr 9:82,673,871...82,699,577
Ensembl chr 9:82,680,384...82,699,551
G
Ostm1
osteoclastogenesis associated transmembrane protein 1
increases expression
ISO
avobenzone results in increased expression of OSTM1 mRNA
CTD
PMID:31016361
NCBI chr20:47,394,979...47,430,304
Ensembl chr20:47,395,014...47,430,284
G
Otud1
OTU deubiquitinase 1
increases expression
ISO
avobenzone results in increased expression of OTUD1 mRNA
CTD
PMID:31016361
NCBI chr17:86,406,643...86,410,670
Ensembl chr17:86,408,151...86,409,518
G
P2rx7
purinergic receptor P2X 7
decreases expression
ISO
avobenzone results in decreased expression of P2RX7 mRNA
CTD
PMID:31016361
NCBI chr12:39,353,613...39,396,042
Ensembl chr12:39,353,613...39,396,042
G
P2ry1
purinergic receptor P2Y1
decreases expression
ISO
avobenzone results in decreased expression of P2RY1 mRNA
CTD
PMID:31016361
NCBI chr 2:151,314,818...151,320,312
Ensembl chr 2:151,314,818...151,320,319
G
Pappa2
pappalysin 2
decreases expression
ISO
avobenzone results in decreased expression of PAPPA2 mRNA
CTD
PMID:31016361
NCBI chr13:76,389,150...76,660,248
Ensembl chr13:76,389,150...76,660,245
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
avobenzone results in increased expression of PAPSS2 mRNA
CTD
PMID:31016361
NCBI chr 1:251,145,264...251,230,716
Ensembl chr 1:251,145,253...251,230,715
G
Pard3
par-3 family cell polarity regulator
increases expression
ISO
avobenzone results in increased expression of PARD3 mRNA
CTD
PMID:31016361
NCBI chr19:60,017,746...60,580,628
Ensembl chr19:60,017,746...60,580,651
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
avobenzone results in decreased expression of PCK2 mRNA
CTD
PMID:31016361
NCBI chr15:34,216,735...34,224,357
Ensembl chr15:34,216,833...34,224,193
G
Pclo
piccolo (presynaptic cytomatrix protein)
decreases expression
ISO
avobenzone results in decreased expression of PCLO mRNA
CTD
PMID:31016361
NCBI chr 4:16,454,904...17,058,921
Ensembl chr 4:16,454,904...17,058,921
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
avobenzone results in decreased expression of PCNA protein
CTD
PMID:29981360
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
G
PCOLCE2
procollagen C-endopeptidase enhancer 2
increases expression
ISO
avobenzone results in increased expression of PCOLCE2 mRNA
CTD
PMID:31016361
NCBI chr 8:103,459,219...103,484,557
Ensembl chr 8:103,459,161...103,484,535
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
increases expression
ISO
avobenzone results in increased expression of PCSK9 mRNA
CTD
PMID:31016361
NCBI chr 5:126,031,368...126,053,726
Ensembl chr 5:126,031,368...126,053,726
G
Pdcd5
programmed cell death 5
increases expression
ISO
avobenzone results in increased expression of PDCD5 mRNA
CTD
PMID:31016361
NCBI chr 1:91,173,473...91,178,801
Ensembl chr 1:91,173,473...91,178,801 Ensembl chr 1:91,173,473...91,178,801
G
Pde5a
phosphodiesterase 5A
increases expression
ISO
avobenzone results in increased expression of PDE5A mRNA
CTD
PMID:31016361
NCBI chr 2:226,899,604...227,044,916
Ensembl chr 2:226,900,619...227,041,576
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
ISO
avobenzone results in increased expression of PDIA4 mRNA
CTD
PMID:31016361
NCBI chr 4:77,470,636...77,489,535
Ensembl chr 4:77,470,636...77,489,535
G
Pdk1
pyruvate dehydrogenase kinase 1
increases expression
ISO
avobenzone results in increased expression of PDK1 mRNA
CTD
PMID:31016361
NCBI chr 3:58,530,870...58,561,494
Ensembl chr 3:58,530,870...58,558,027
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
increases expression
ISO
avobenzone results in increased expression of PDP2 mRNA
CTD
PMID:31016361
NCBI chr19:597,427...601,556
Ensembl chr19:597,427...601,469
G
Pdxdc1
pyridoxal-dependent decarboxylase domain containing 1
increases expression
ISO
avobenzone results in increased expression of PDXDC1 mRNA
CTD
PMID:31016361
NCBI chr10:3,232,794...3,321,438
Ensembl chr10:3,232,794...3,321,412
G
Pet100
PET100 cytochrome c oxidase chaperone
increases expression
ISO
avobenzone results in increased expression of PET100 mRNA
CTD
PMID:31016361
NCBI chr12:2,170,630...2,173,259
Ensembl chr12:2,170,630...2,173,251
G
Pex13
peroxisomal biogenesis factor 13
increases expression
ISO
avobenzone results in increased expression of PEX13 mRNA
CTD
PMID:31016361
NCBI chr14:108,394,299...108,411,994
Ensembl chr14:108,394,303...108,412,823
G
Pfdn4
prefoldin subunit 4
increases expression
ISO
avobenzone results in increased expression of PFDN4 mRNA
CTD
PMID:31016361
NCBI chr 3:168,124,634...168,132,739
Ensembl chr 3:168,124,673...168,132,786
G
Phactr3
phosphatase and actin regulator 3
decreases expression
ISO
avobenzone results in decreased expression of PHACTR3 mRNA
CTD
PMID:31016361
NCBI chr 3:173,798,542...173,871,386
Ensembl chr 3:173,798,545...173,871,904
G
Phex
phosphate regulating endopeptidase homolog, X-linked
decreases expression
ISO
avobenzone results in decreased expression of PHEX mRNA
CTD
PMID:31016361
NCBI chr X:40,460,047...40,717,982
Ensembl chr X:40,460,047...40,717,982
G
Phtf2
putative homeodomain transcription factor 2
increases expression
ISO
avobenzone results in increased expression of PHTF2 mRNA
CTD
PMID:31016361
NCBI chr 4:10,823,191...10,938,273
Ensembl chr 4:10,823,281...10,938,318
G
Pi4k2a
phosphatidylinositol 4-kinase type 2 alpha
increases expression
ISO
avobenzone results in increased expression of PI4K2A mRNA
CTD
PMID:31016361
NCBI chr 1:261,337,594...261,362,509
Ensembl chr 1:261,337,594...261,362,509
G
Pidd1
p53-induced death domain protein 1
increases expression
ISO
avobenzone results in increased expression of PIDD1 mRNA
CTD
PMID:31016361
NCBI chr 1:214,418,751...214,423,959
Ensembl chr 1:214,419,240...214,423,881 Ensembl chr 1:214,419,240...214,423,881
G
Pigm
phosphatidylinositol glycan anchor biosynthesis, class M
decreases expression
ISO
avobenzone results in decreased expression of PIGM mRNA
CTD
PMID:31016361
NCBI chr13:90,759,260...90,762,957
Ensembl chr13:90,759,260...90,762,957
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
increases expression
ISO
avobenzone results in increased expression of PIK3C2A mRNA
CTD
PMID:31016361
NCBI chr 1:185,210,922...185,326,314
Ensembl chr 1:185,210,922...185,326,314
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
increases expression
ISO
avobenzone results in increased expression of PIK3IP1 mRNA
CTD
PMID:31016361
NCBI chr14:83,559,397...83,572,481
Ensembl chr14:83,560,541...83,572,473
G
Plau
plasminogen activator, urokinase
increases expression
ISO
avobenzone results in increased expression of PLAU mRNA
CTD
PMID:31016361
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
G
Plekhg3
pleckstrin homology and RhoGEF domain containing G3
increases expression
ISO
avobenzone results in increased expression of PLEKHG3 mRNA
CTD
PMID:31016361
NCBI chr 6:99,612,993...99,655,753
Ensembl chr 6:99,625,306...99,655,362
G
Plin2
perilipin 2
decreases expression
ISO
avobenzone results in decreased expression of PLIN2 mRNA
CTD
PMID:31016361
NCBI chr 5:104,984,413...105,010,863
Ensembl chr 5:104,984,414...105,010,857
G
Plpp6
phospholipid phosphatase 6
decreases expression
ISO
avobenzone results in decreased expression of PLPP6 mRNA
CTD
PMID:31016361
NCBI chr 1:247,084,228...247,087,080
Ensembl chr 1:247,084,228...247,087,077
G
Pnisr
PNN interacting serine and arginine rich protein
increases expression
ISO
avobenzone results in increased expression of PNISR mRNA
CTD
PMID:31016361
NCBI chr 5:35,991,028...36,017,952
Ensembl chr 5:35,991,068...36,017,944
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression multiple interactions
ISO
avobenzone results in increased expression of PPARA mRNA [avobenzone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARA mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] avobenzone results in increased expression of PPARG mRNA
CTD
PMID:31016361 PMID:32407875
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Ppfibp1
PPFIA binding protein 1
increases expression
ISO
avobenzone results in increased expression of PPFIBP1 mRNA
CTD
PMID:31016361
NCBI chr 4:181,285,179...181,428,157
Ensembl chr 4:181,286,455...181,428,157
G
Ppm1k
protein phosphatase, Mg2+/Mn2+ dependent, 1K
increases expression
ISO
avobenzone results in increased expression of PPM1K mRNA
CTD
PMID:31016361
NCBI chr 4:88,694,395...88,721,374
Ensembl chr 4:88,694,583...88,718,533
G
Ppp1r18
protein phosphatase 1, regulatory subunit 18
increases expression
ISO
avobenzone results in increased expression of PPP1R18 mRNA
CTD
PMID:31016361
NCBI chr20:3,372,412...3,397,351
Ensembl chr20:3,372,413...3,397,039
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
avobenzone results in decreased expression of PPP1R3C mRNA
CTD
PMID:31016361
NCBI chr 1:255,371,830...255,376,833
Ensembl chr 1:255,371,810...255,376,833
G
Prkg1
protein kinase cGMP-dependent 1
decreases expression
ISO
avobenzone results in decreased expression of PRKG1 mRNA
CTD
PMID:31016361
NCBI chr 1:248,982,039...250,300,952
G
Prmt2
protein arginine methyltransferase 2
increases expression
ISO
avobenzone results in increased expression of PRMT2 mRNA
CTD
PMID:31016361
NCBI chr20:13,154,513...13,212,613
Ensembl chr20:13,156,241...13,212,606
G
Prmt6
protein arginine methyltransferase 6
decreases expression
ISO
avobenzone results in decreased expression of PRMT6 mRNA
CTD
PMID:31016361
NCBI chr 2:213,173,403...213,180,721
Ensembl chr 2:213,173,403...213,178,632 Ensembl chr 2:213,173,403...213,178,632
G
Prmt8
protein arginine methyltransferase 8
decreases expression
ISO
avobenzone results in decreased expression of PRMT8 mRNA
CTD
PMID:31016361
NCBI chr 4:160,253,409...160,334,647
Ensembl chr 4:160,253,073...160,334,910
G
Prss23
serine protease 23
decreases expression
ISO
avobenzone results in decreased expression of PRSS23 mRNA
CTD
PMID:31016361
NCBI chr 1:153,732,528...153,742,111
Ensembl chr 1:153,732,532...153,752,541
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
avobenzone results in decreased expression of PSAT1 mRNA
CTD
PMID:31016361
NCBI chr 1:233,124,089...233,145,941
Ensembl chr 1:233,124,092...233,145,941
G
Pskh1
protein serine kinase H1
decreases expression
ISO
avobenzone results in decreased expression of PSKH1 mRNA
CTD
PMID:31016361
NCBI chr19:37,873,515...37,905,625
Ensembl chr19:37,873,515...37,905,625
G
Ptafr
platelet-activating factor receptor
increases expression
ISO
avobenzone results in increased expression of PTAFR mRNA
CTD
PMID:31016361
NCBI chr 5:150,746,284...150,775,675
Ensembl chr 5:150,754,021...150,775,672
G
Ptpdc1
protein tyrosine phosphatase domain containing 1
increases expression
ISO
avobenzone results in increased expression of PTPDC1 mRNA
CTD
PMID:31016361
NCBI chr17:16,333,369...16,381,887
Ensembl chr17:16,333,415...16,380,573
G
Qprt
quinolinate phosphoribosyltransferase
increases expression
ISO
avobenzone results in increased expression of QPRT mRNA
CTD
PMID:31016361
NCBI chr 1:198,544,262...198,559,556
Ensembl chr 1:198,544,262...198,559,568
G
Rab11fip4
RAB11 family interacting protein 4
increases expression
ISO
avobenzone results in increased expression of RAB11FIP4 mRNA
CTD
PMID:31016361
NCBI chr10:66,942,363...67,051,672
Ensembl chr10:66,942,398...67,048,308
G
Rac2
Rac family small GTPase 2
increases expression
ISO
avobenzone results in increased expression of RAC2 mRNA
CTD
PMID:31016361
NCBI chr 7:119,769,708...119,797,111
Ensembl chr 7:119,783,849...119,797,098
G
Rad18
RAD18 E3 ubiquitin protein ligase
increases expression
ISO
avobenzone results in increased expression of RAD18 mRNA
CTD
PMID:31016361
NCBI chr 4:144,537,329...144,620,606
Ensembl chr 4:144,536,729...144,620,731
G
Raet1e
retinoic acid early transcript 1E
decreases expression
ISO
avobenzone results in decreased expression of RAET1E mRNA
CTD
PMID:31016361
NCBI chr 1:1,101,666...1,120,340
Ensembl chr 1:1,101,965...1,116,926
G
Ranbp1
RAN binding protein 1
increases expression
ISO
avobenzone results in increased expression of RANBP1 mRNA
CTD
PMID:31016361
NCBI chr11:86,890,585...86,898,818
Ensembl chr11:86,890,585...86,898,818
G
Ranbp6
RAN binding protein 6
decreases expression
ISO
avobenzone results in decreased expression of RANBP6 mRNA
CTD
PMID:31016361
NCBI chr 1:247,980,976...247,985,553
Ensembl chr 1:247,982,180...247,985,497
G
Rasgrp1
RAS guanyl releasing protein 1
decreases expression
ISO
avobenzone results in decreased expression of RASGRP1 mRNA
CTD
PMID:31016361
NCBI chr 3:108,984,029...109,044,420
Ensembl chr 3:108,984,029...109,044,420
G
Rassf10
Ras association domain family member 10
decreases expression
ISO
avobenzone results in decreased expression of RASSF10 mRNA
CTD
PMID:31016361
NCBI chr 1:177,764,177...177,769,531
Ensembl chr 1:177,764,445...177,765,968
G
Rbl2
RB transcriptional corepressor like 2
increases expression
ISO
avobenzone results in increased expression of RBL2 mRNA
CTD
PMID:31016361
NCBI chr19:17,300,088...17,346,865
Ensembl chr19:17,300,089...17,346,808
G
Rbm45
RNA binding motif protein 45
decreases expression
ISO
avobenzone results in decreased expression of RBM45 mRNA
CTD
PMID:31016361
NCBI chr 3:63,220,660...63,235,638
Ensembl chr 3:63,220,647...63,235,648
G
Rbm5
RNA binding motif protein 5
increases expression
ISO
avobenzone results in increased expression of RBM5 mRNA
CTD
PMID:31016361
NCBI chr 8:116,502,941...116,532,178
Ensembl chr 8:116,502,937...116,532,169
G
RGD1563941
similar to hypothetical protein FLJ20010
decreases expression
ISO
avobenzone results in decreased expression of C11ORF71 mRNA
CTD
PMID:31016361
NCBI chr 8:52,829,196...52,829,610
Ensembl chr 8:52,829,085...52,830,609
G
RGD1564865
similar to 20-alpha-hydroxysteroid dehydrogenase
increases expression
ISO
avobenzone results in increased expression of AKR1C1 mRNA
CTD
PMID:31016361
NCBI chr17:69,468,427...69,497,132
Ensembl chr17:69,468,427...69,497,132
G
Rgs5
regulator of G-protein signaling 5
decreases expression
ISO
avobenzone results in decreased expression of RGS5 mRNA
CTD
PMID:31016361
NCBI chr13:87,966,820...88,002,831
Ensembl chr13:87,966,758...88,003,035
G
Rnase4
ribonuclease A family member 4
increases expression
ISO
avobenzone results in increased expression of RNASE4 mRNA
CTD
PMID:31016361
NCBI chr15:28,018,040...28,035,395
Ensembl chr15:28,018,040...28,035,389 Ensembl chr15:28,018,040...28,035,389
G
Rnf6
ring finger protein 6
increases expression
ISO
avobenzone results in increased expression of RNF6 mRNA
CTD
PMID:31016361
NCBI chr12:10,574,168...10,583,196
Ensembl chr12:10,574,168...10,583,208
G
Rps6
ribosomal protein S6
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of RPS6 protein
CTD
PMID:29981360
NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148 Ensembl chr 5:105,197,857...105,200,148
G
Rps6ka6
ribosomal protein S6 kinase A6
decreases expression
ISO
avobenzone results in decreased expression of RPS6KA6 mRNA
CTD
PMID:31016361
NCBI chr X:82,641,679...82,743,771
Ensembl chr X:82,641,687...82,743,753
G
Rps6kb1
ribosomal protein S6 kinase B1
increases phosphorylation
ISO
avobenzone results in increased phosphorylation of RPS6KB1 protein
CTD
PMID:29981360
NCBI chr10:73,824,200...73,865,503
Ensembl chr10:73,824,202...73,865,364
G
Rptn
repetin
decreases expression
ISO
avobenzone results in decreased expression of RPTN mRNA
CTD
PMID:31016361
NCBI chr 2:193,722,394...193,729,040
Ensembl chr 2:193,724,248...193,728,302
G
Rragd
Ras-related GTP binding D
increases expression
ISO
avobenzone results in increased expression of RRAGD mRNA
CTD
PMID:31016361
NCBI chr 5:48,224,994...48,260,691
Ensembl chr 5:48,224,994...48,260,685
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression
ISO
avobenzone results in increased expression of RSAD2 mRNA
CTD
PMID:31016361
NCBI chr 6:45,655,947...45,669,083
Ensembl chr 6:45,655,954...45,669,148
G
Rsbn1l
round spermatid basic protein 1-like
increases expression
ISO
avobenzone results in increased expression of RSBN1L mRNA
CTD
PMID:31016361
NCBI chr 4:10,748,745...10,809,142
Ensembl chr 4:10,748,745...10,809,142
G
Rundc1
RUN domain containing 1
decreases expression
ISO
avobenzone results in decreased expression of RUNDC1 mRNA
CTD
PMID:31016361
NCBI chr10:89,339,003...89,349,230
Ensembl chr10:89,339,029...89,347,835
G
Samd13
sterile alpha motif domain containing 13
decreases expression
ISO
avobenzone results in decreased expression of SAMD13 mRNA
CTD
PMID:31016361
NCBI chr 2:252,500,143...252,537,490
Ensembl chr 2:252,500,146...252,505,971
G
Samd4a
sterile alpha motif domain containing 4A
increases expression
ISO
avobenzone results in increased expression of SAMD4A mRNA
CTD
PMID:31016361
NCBI chr15:23,666,543...23,879,067
Ensembl chr15:23,665,202...23,878,539
G
Samd9
sterile alpha motif domain containing 9
decreases expression
ISO
avobenzone results in decreased expression of SAMD9 mRNA
CTD
PMID:31016361
NCBI chr 4:28,304,967...28,324,637
Ensembl chr 4:28,305,002...28,310,178
G
Scara3
scavenger receptor class A, member 3
increases expression
ISO
avobenzone results in increased expression of SCARA3 mRNA
CTD
PMID:31016361
NCBI chr15:42,605,505...42,638,409
Ensembl chr15:42,605,473...42,638,392
G
Scd
stearoyl-CoA desaturase
increases expression
ISO
avobenzone results in increased expression of SCD mRNA
CTD
PMID:31016361
NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
G
Scml1
Scm polycomb group protein like 1
increases expression
ISO
avobenzone results in increased expression of SCML1 mRNA
CTD
PMID:31016361
NCBI chr X:34,676,728...34,694,251
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
ISO
avobenzone results in increased expression of SDF2L1 mRNA
CTD
PMID:31016361
NCBI chr11:88,122,271...88,124,513
Ensembl chr11:88,122,271...88,124,513
G
Sec24d
SEC24 homolog D, COPII coat complex component
increases expression
ISO
avobenzone results in increased expression of SEC24D mRNA
CTD
PMID:31016361
NCBI chr 2:227,455,704...227,562,801
Ensembl chr 2:227,455,722...227,562,319
G
Sema6d
semaphorin 6D
decreases expression
ISO
avobenzone results in decreased expression of SEMA6D mRNA
CTD
PMID:31016361
NCBI chr 3:116,899,906...116,958,059
Ensembl chr 3:116,899,878...116,958,050
G
Sephs2
selenophosphate synthetase 2
decreases expression
ISO
avobenzone results in decreased expression of SEPHS2 mRNA
CTD
PMID:31016361
NCBI chr 1:198,719,158...198,721,476
Ensembl chr 1:198,719,162...198,721,476
G
Sft2d3
SFT2 domain containing 3
decreases expression
ISO
avobenzone results in decreased expression of SFT2D3 mRNA
CTD
PMID:31016361
NCBI chr18:24,691,281...24,693,481
Ensembl chr18:24,691,281...24,693,481
G
Sh3bgr
SH3 domain binding glutamate-rich protein
decreases expression
ISO
avobenzone results in decreased expression of SH3BGR mRNA
CTD
PMID:31016361
NCBI chr11:36,555,354...36,579,537
Ensembl chr11:36,555,416...36,579,535
G
Slc12a6
solute carrier family 12, member 6
increases expression
ISO
avobenzone results in increased expression of SLC12A6 mRNA
CTD
PMID:31016361
NCBI chr 3:103,752,213...103,852,686
Ensembl chr 3:103,753,238...103,852,686
G
Slc16a9
solute carrier family 16, member 9
decreases expression
ISO
avobenzone results in decreased expression of SLC16A9 mRNA
CTD
PMID:31016361
NCBI chr20:19,634,280...19,675,358
G
Slc17a5
solute carrier family 17 member 5
increases expression
ISO
avobenzone results in increased expression of SLC17A5 mRNA
CTD
PMID:31016361
NCBI chr 8:85,891,245...85,926,466
Ensembl chr 8:85,891,257...85,926,450
G
Slc25a37
solute carrier family 25 member 37
increases expression
ISO
avobenzone results in increased expression of SLC25A37 mRNA
CTD
PMID:31016361
NCBI chr15:51,125,764...51,168,384
Ensembl chr15:51,128,268...51,168,384
G
Slc2a12
solute carrier family 2 member 12
increases expression
ISO
avobenzone results in increased expression of SLC2A12 mRNA
CTD
PMID:31016361
NCBI chr 1:24,003,625...24,056,373
Ensembl chr 1:24,003,625...24,056,373
G
Slc2a3
solute carrier family 2 member 3
increases expression
ISO
avobenzone results in increased expression of SLC2A3 mRNA
CTD
PMID:31016361
NCBI chr 4:155,549,991...155,626,018
Ensembl chr 4:155,408,233...155,631,856 Ensembl chr 4:155,408,233...155,631,856
G
Slc2a8
solute carrier family 2 member 8
increases expression
ISO
avobenzone results in increased expression of SLC2A8 mRNA
CTD
PMID:31016361
NCBI chr 3:12,020,227...12,029,920
Ensembl chr 3:12,020,229...12,029,877
G
Slc33a1
solute carrier family 33 member 1
increases expression
ISO
avobenzone results in increased expression of SLC33A1 mRNA
CTD
PMID:31016361
NCBI chr 2:154,520,170...154,542,981
Ensembl chr 2:154,520,087...154,542,919
G
Slc5a3
solute carrier family 5 member 3
increases expression
ISO
avobenzone results in increased expression of SLC5A3 mRNA
CTD
PMID:31016361
NCBI chr11:32,229,366...32,231,812
G
Slc6a6
solute carrier family 6 member 6
increases expression
ISO
avobenzone results in increased expression of SLC6A6 mRNA
CTD
PMID:31016361
NCBI chr 4:123,638,619...123,713,469
Ensembl chr 4:123,642,210...123,713,464
G
Smim5
small integral membrane protein 5
decreases expression
ISO
avobenzone results in decreased expression of SMIM5 mRNA
CTD
PMID:31016361
NCBI chr10:104,451,222...104,457,002
Ensembl chr10:104,451,222...104,457,001
G
Smtn
smoothelin
increases expression
ISO
avobenzone results in increased expression of SMTN mRNA
CTD
PMID:31016361
NCBI chr14:83,755,141...83,776,871
Ensembl chr14:83,755,142...83,776,863
G
Snrnp27
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
increases expression
ISO
avobenzone results in increased expression of SNRNP27 mRNA
CTD
PMID:31016361
NCBI chr 4:118,478,075...118,487,633
Ensembl chr 4:118,478,075...118,534,280
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
avobenzone results in increased expression of SOCS3 mRNA
CTD
PMID:31016361
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
G
Socs4
suppressor of cytokine signaling 4
decreases expression
ISO
avobenzone results in decreased expression of SOCS4 mRNA
CTD
PMID:31016361
NCBI chr15:24,056,383...24,070,868
Ensembl chr15:24,056,383...24,070,857
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
avobenzone results in increased expression of SOX9 mRNA
CTD
PMID:31016361
NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
G
Sparc
secreted protein acidic and cysteine rich
increases expression
ISO
avobenzone results in increased expression of SPARC mRNA
CTD
PMID:31016361
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
G
Spink6
serine peptidase inhibitor, Kazal type 6
increases expression
ISO
avobenzone results in increased expression of SPINK6 mRNA
CTD
PMID:31016361
NCBI chr X:43,033,066...43,044,975
Ensembl chr X:43,033,066...43,044,975 Ensembl chr 2:43,033,066...43,044,975
G
Sqle
squalene epoxidase
increases expression
ISO
avobenzone results in increased expression of SQLE mRNA
CTD
PMID:31016361
NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
G
Sqstm1
sequestosome 1
increases expression
ISO
avobenzone results in increased expression of SQSTM1 mRNA
CTD
PMID:31016361
NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
G
Stc2
stanniocalcin 2
decreases expression
ISO
avobenzone results in decreased expression of STC2 mRNA
CTD
PMID:31016361
NCBI chr10:16,542,909...16,552,675
Ensembl chr10:16,542,882...16,553,295
G
Stk32c
serine/threonine kinase 32C
increases expression
ISO
avobenzone results in increased expression of STK32C mRNA
CTD
PMID:31016361
NCBI chr 1:211,440,335...211,520,699
Ensembl chr 1:211,440,335...211,520,699
G
Stx19
syntaxin 19
decreases expression
ISO
avobenzone results in decreased expression of STX19 mRNA
CTD
PMID:31016361
NCBI chr 7:1,145,002...1,149,978
G
Sugct
succinylCoA:glutarate-CoA transferase
increases expression
ISO
avobenzone results in increased expression of SUGCT mRNA
CTD
PMID:31016361
NCBI chr17:49,991,314...51,030,950
G
Sult1e1
sulfotransferase family 1E member 1
decreases expression
ISO
avobenzone results in decreased expression of SULT1E1 mRNA
CTD
PMID:31016361
NCBI chr14:22,070,861...22,089,264
Ensembl chr14:22,072,024...22,089,248
G
Suox
sulfite oxidase
decreases expression
ISO
avobenzone results in decreased expression of SUOX mRNA
CTD
PMID:31016361
NCBI chr 7:3,098,228...3,102,179
Ensembl chr 7:3,098,245...3,102,142
G
Sybu
syntabulin
decreases expression
ISO
avobenzone results in decreased expression of SYBU mRNA
CTD
PMID:31016361
NCBI chr 7:83,600,614...83,670,121
Ensembl chr 7:83,600,617...83,670,356
G
Sync
syncoilin, intermediate filament protein
decreases expression
ISO
avobenzone results in decreased expression of SYNC mRNA
CTD
PMID:31016361
NCBI chr 5:147,476,136...147,500,193
Ensembl chr 5:147,476,221...147,498,902
G
Taf13
TATA-box binding protein associated factor 13
increases expression
ISO
avobenzone results in increased expression of TAF13 mRNA
CTD
PMID:31016361
NCBI chr 2:211,359,623...211,370,285
Ensembl chr 2:211,359,623...211,370,284
G
Tbc1d2
TBC1 domain family, member 2
increases expression
ISO
avobenzone results in increased expression of TBC1D2 mRNA
CTD
PMID:31016361
NCBI chr 5:62,213,001...62,261,467
Ensembl chr 5:62,212,982...62,260,105
G
Tent5c
terminal nucleotidyltransferase 5C
increases expression
ISO
avobenzone results in increased expression of TENT5C mRNA
CTD
PMID:31016361
NCBI chr 2:202,797,766...202,816,562
Ensembl chr 2:202,798,198...202,816,562
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
avobenzone results in increased expression of TFPI2 mRNA
CTD
PMID:31016361
NCBI chr 4:28,947,951...28,953,261
Ensembl chr 4:28,947,965...28,953,067
G
Tgfbr2
transforming growth factor, beta receptor 2
increases expression
ISO
avobenzone results in increased expression of TGFBR2 mRNA
CTD
PMID:31016361
NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
G
Tgm1
transglutaminase 1
decreases expression
ISO
avobenzone results in decreased expression of TGM1 mRNA
CTD
PMID:31016361
NCBI chr15:34,378,136...34,393,150
Ensembl chr15:34,378,148...34,392,066
G
Themis2
thymocyte selection associated family member 2
increases expression
ISO
avobenzone results in increased expression of THEMIS2 mRNA
CTD
PMID:31016361
NCBI chr 5:150,971,795...150,986,596
Ensembl chr 5:150,970,909...150,987,081
G
Tm9sf1
transmembrane 9 superfamily member 1
increases expression
ISO
avobenzone results in increased expression of TM9SF1 mRNA
CTD
PMID:31016361
NCBI chr15:34,314,645...34,322,172
Ensembl chr15:34,314,656...34,322,115
G
Tmem139
transmembrane protein 139
decreases expression
ISO
avobenzone results in decreased expression of TMEM139 mRNA
CTD
PMID:31016361
NCBI chr 4:71,648,705...71,651,861
Ensembl chr 4:71,650,575...71,651,438
G
Tmem185b
transmembrane protein 185B
decreases expression
ISO
avobenzone results in decreased expression of TMEM185B mRNA
CTD
PMID:31016361
NCBI chr13:35,554,621...35,557,952
Ensembl chr13:35,554,964...35,556,016
G
Tmem250
transmembrane protein 250
decreases expression
ISO
avobenzone results in decreased expression of TMEM250 mRNA
CTD
PMID:31016361
NCBI chr 3:3,590,783...3,594,475
Ensembl chr 3:3,590,783...3,594,475
G
Tmem67
transmembrane protein 67
decreases expression
ISO
avobenzone results in decreased expression of TMEM67 mRNA
CTD
PMID:31016361
NCBI chr 5:25,666,138...25,721,056
Ensembl chr 5:25,666,137...25,721,072
G
Tmem97
transmembrane protein 97
increases expression
ISO
avobenzone results in increased expression of TMEM97 mRNA
CTD
PMID:31016361
NCBI chr10:65,811,455...65,820,538
Ensembl chr10:65,811,456...65,820,538
G
Tnfrsf11b
TNF receptor superfamily member 11B
multiple interactions
ISO
avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of TNFRSF11B mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein]
CTD
PMID:31016361
NCBI chr 7:93,798,580...93,826,586
Ensembl chr 7:93,798,545...93,826,665
G
Tnfsf9
TNF superfamily member 9
increases expression
ISO
avobenzone results in increased expression of TNFSF9 mRNA
CTD
PMID:31016361
NCBI chr 9:9,909,942...9,912,276
Ensembl chr 9:9,909,948...9,912,276
G
Top3b
DNA topoisomerase III beta
increases expression
ISO
avobenzone results in increased expression of TOP3B mRNA
CTD
PMID:31016361
NCBI chr11:88,346,305...88,374,896
Ensembl chr11:88,346,313...88,374,679
G
Tram1l1
translocation associated membrane protein 1-like 1
decreases expression
ISO
avobenzone results in decreased expression of TRAM1L1 mRNA
CTD
PMID:31016361
NCBI chr 2:228,544,418...228,546,599
Ensembl chr 2:228,544,418...228,546,599
G
Trim25
tripartite motif-containing 25
decreases expression
ISO
avobenzone results in decreased expression of TRIM25 mRNA
CTD
PMID:31016361
NCBI chr10:76,343,847...76,362,159
Ensembl chr10:76,343,847...76,362,145
G
Trim69
tripartite motif-containing 69
decreases expression
ISO
avobenzone results in decreased expression of TRIM69 mRNA
CTD
PMID:31016361
NCBI chr 3:114,103,011...114,123,293
Ensembl chr 3:114,102,875...114,126,523
G
Tsc22d3
TSC22 domain family, member 3
increases expression
ISO
avobenzone results in increased expression of TSC22D3 mRNA
CTD
PMID:31016361
NCBI chr X:111,884,285...111,944,693
Ensembl chr X:111,884,295...111,887,906
G
Tsen2
tRNA splicing endonuclease subunit 2
decreases expression
ISO
avobenzone results in decreased expression of TSEN2 mRNA
CTD
PMID:31016361
NCBI chr 4:147,455,506...147,490,869
Ensembl chr 4:147,455,533...147,490,733
G
Tspan1
tetraspanin 1
increases expression
ISO
avobenzone results in increased expression of TSPAN1 mRNA
CTD
PMID:31016361
NCBI chr 5:135,019,206...135,032,412
Ensembl chr 5:135,019,778...135,025,084
G
Tspyl5
TSPY-like 5
decreases expression
ISO
avobenzone results in decreased expression of TSPYL5 mRNA
CTD
PMID:31016361
NCBI chr 7:72,323,764...72,328,228
Ensembl chr 7:72,326,896...72,328,128
G
Ttbk2
tau tubulin kinase 2
increases expression
ISO
avobenzone results in increased expression of TTBK2 mRNA
CTD
PMID:31016361
NCBI chr 3:112,677,932...112,789,615
Ensembl chr 3:112,684,152...112,789,289
G
Ttc30b
tetratricopeptide repeat domain 30B
decreases expression
ISO
avobenzone results in decreased expression of TTC30B mRNA
CTD
PMID:31016361
NCBI chr 3:62,758,754...62,761,325
Ensembl chr 3:62,758,758...62,761,325
G
Ttc7b
tetratricopeptide repeat domain 7B
increases expression
ISO
avobenzone results in increased expression of TTC7B mRNA
CTD
PMID:31016361
NCBI chr 6:124,316,444...124,528,058
Ensembl chr 6:124,316,445...124,429,701
G
Ttc9c
tetratricopeptide repeat domain 9C
increases expression
ISO
avobenzone results in increased expression of TTC9C mRNA
CTD
PMID:31016361
NCBI chr 1:225,003,859...225,014,867
Ensembl chr 1:225,005,017...225,014,538
G
Tubgcp3
tubulin, gamma complex associated protein 3
increases expression
ISO
avobenzone results in increased expression of TUBGCP3 mRNA
CTD
PMID:31016361
NCBI chr16:82,184,362...82,245,041
Ensembl chr16:82,184,387...82,245,041
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
avobenzone results in increased expression of TXNRD1 mRNA
CTD
PMID:31016361
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
avobenzone results in increased expression of TXNRD2 mRNA
CTD
PMID:31016361
NCBI chr11:86,667,994...86,716,063
Ensembl chr11:86,667,997...86,716,254
G
Uqcc1
ubiquinol-cytochrome c reductase complex assembly factor 1
increases expression
ISO
avobenzone results in increased expression of UQCC1 mRNA
CTD
PMID:31016361
NCBI chr 3:151,384,965...151,474,112
Ensembl chr 3:151,384,954...151,474,135
G
Usp12
ubiquitin specific peptidase 12
increases expression
ISO
avobenzone results in increased expression of USP12 mRNA
CTD
PMID:31016361
NCBI chr12:10,037,686...10,087,685
Ensembl chr12:10,063,117...10,087,685
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
avobenzone results in increased expression of VEGFA protein
CTD
PMID:25617811
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
increases expression
ISO
avobenzone results in increased expression of WDHD1 mRNA
CTD
PMID:31016361
NCBI chr15:24,021,674...24,056,073
Ensembl chr15:24,021,674...24,056,073
G
Wdr5b
WD repeat domain 5B
decreases expression
ISO
avobenzone results in decreased expression of WDR5B mRNA
CTD
PMID:31016361
NCBI chr11:67,645,959...67,647,818
Ensembl chr11:67,645,965...67,647,818
G
Wnt9a
Wnt family member 9A
decreases expression
ISO
avobenzone results in decreased expression of WNT9A mRNA
CTD
PMID:31016361
NCBI chr10:45,659,045...45,686,103
Ensembl chr10:45,659,143...45,681,393
G
Xaf1
XIAP associated factor 1
decreases expression
ISO
avobenzone results in decreased expression of XAF1 mRNA
CTD
PMID:31016361
NCBI chr10:58,860,647...58,872,782
Ensembl chr10:58,860,940...58,873,674
G
Xdh
xanthine dehydrogenase
increases expression
ISO
avobenzone results in increased expression of XDH mRNA
CTD
PMID:31016361
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
G
Xk
X-linked Kx blood group
decreases expression
ISO
avobenzone results in decreased expression of XK mRNA
CTD
PMID:31016361
NCBI chr X:14,497,376...14,534,479
Ensembl chr X:14,498,119...14,534,473
G
Zbed3
zinc finger, BED-type containing 3
decreases expression
ISO
avobenzone results in decreased expression of ZBED3 mRNA
CTD
PMID:31016361
NCBI chr 2:25,039,506...25,052,129
Ensembl chr 2:25,041,185...25,052,127
G
Zbtb10
zinc finger and BTB domain containing 10
increases expression
ISO
avobenzone results in increased expression of ZBTB10 mRNA
CTD
PMID:31016361
NCBI chr 2:94,692,939...94,730,976
Ensembl chr 2:94,692,939...94,730,978
G
Zbtb44
zinc finger and BTB domain containing 44
increases expression
ISO
avobenzone results in increased expression of ZBTB44 mRNA
CTD
PMID:31016361
NCBI chr 8:32,165,388...32,223,341
Ensembl chr 8:32,165,810...32,217,476
G
Zdhhc21
zinc finger DHHC-type palmitoyltransferase 21
decreases expression
ISO
avobenzone results in decreased expression of ZDHHC21 mRNA
CTD
PMID:31016361
NCBI chr 5:100,924,621...100,983,412
Ensembl chr 5:100,924,622...100,977,902
G
Zfp112
zinc finger protein 112
decreases expression
ISO
avobenzone results in decreased expression of ZNF112 mRNA
CTD
PMID:31016361
NCBI chr 1:80,944,118...80,959,072
Ensembl chr 1:80,953,275...80,958,908
G
Zfp17
zinc finger protein 585B
decreases expression
ISO
avobenzone results in decreased expression of ZNF585B mRNA
CTD
PMID:31016361
NCBI chr 1:98,614,943...98,631,142
Ensembl chr 1:98,627,372...98,629,936
G
Zfp260
zinc finger protein 260
decreases expression
ISO
avobenzone results in decreased expression of ZNF260 mRNA
CTD
PMID:31016361
NCBI chr 1:88,452,133...88,465,110
Ensembl chr 1:88,451,958...88,453,578 Ensembl chr 1:88,451,958...88,453,578
G
Zfp418
zinc finger protein 418
decreases expression
ISO
avobenzone results in decreased expression of ZNF416 mRNA
CTD
PMID:31016361
NCBI chr 1:69,615,413...69,629,997
Ensembl chr 1:69,615,434...69,629,913
G
Zfp518b
zinc finger protein 518B
decreases expression
ISO
avobenzone results in decreased expression of ZNF518B mRNA
CTD
PMID:31016361
NCBI chr14:76,853,171...76,872,476
Ensembl chr14:76,866,135...76,869,764
G
Zfp605
zinc finger protein 605
decreases expression
ISO
avobenzone results in decreased expression of ZNF605 mRNA
CTD
PMID:31016361
NCBI chr12:52,606,554...52,670,918
Ensembl chr12:52,606,560...52,658,275
G
Zfp606
zinc finger protein 606
decreases expression
ISO
avobenzone results in decreased expression of ZNF606 mRNA
CTD
PMID:31016361
NCBI chr 1:66,229,845...66,256,901
Ensembl chr 1:66,231,763...66,254,989
G
Zfp618
zinc finger protein 618
increases expression
ISO
avobenzone results in increased expression of ZNF618 mRNA
CTD
PMID:31016361
NCBI chr 5:78,806,585...78,972,433
Ensembl chr 5:78,806,607...78,966,813
G
Zfp623
zinc finger protein 623
decreases expression
ISO
avobenzone results in decreased expression of ZNF623 mRNA
CTD
PMID:31016361
NCBI chr 7:116,973,687...116,982,584
Ensembl chr 7:116,980,076...116,981,946
G
Zfp69
zinc finger protein 69
decreases expression
ISO
avobenzone results in decreased expression of ZFP69 mRNA
CTD
PMID:31016361
NCBI chr 5:139,856,457...139,871,896
G
Zfp74
zinc finger protein 74
increases expression
ISO
avobenzone results in increased expression of ZNF569 mRNA
CTD
PMID:31016361
NCBI chr 1:88,231,016...88,257,565
Ensembl chr 1:88,232,617...88,240,057 Ensembl chr 1:88,232,617...88,240,057
G
Zfp870
zinc finger protein 870
increases expression
ISO
avobenzone results in increased expression of ZNF670 mRNA
CTD
PMID:31016361
NCBI chr 7:15,158,673...15,172,489
Ensembl chr 7:15,159,422...15,163,866
G
Zfp879
zinc finger protein 879
decreases expression
ISO
avobenzone results in decreased expression of ZNF879 mRNA
CTD
PMID:31016361
NCBI chr10:36,326,633...36,336,628
Ensembl chr10:36,326,633...36,336,628
G
Zfp951
zinc finger protein 951
decreases expression
ISO
avobenzone results in decreased expression of ZNF844 mRNA
CTD
PMID:31016361
NCBI chr14:6,280,767...6,284,145
Ensembl chr14:6,281,336...6,284,145 Ensembl chr14:6,281,336...6,284,145
G
Znf658
zinc finger protein 658
decreases expression
ISO
avobenzone results in decreased expression of ZNF658 mRNA
CTD
PMID:31016361
NCBI chr13:13,579,706...13,734,552
G
Znrd1as
zinc ribbon domain containing 1 antisense
decreases expression
ISO
avobenzone results in decreased expression of ZNRD1ASP mRNA
CTD
PMID:31016361
NCBI chr 9:18,489,284...18,490,450
Ensembl chr 9:18,489,284...18,490,450
G
Zscan26
zinc finger and SCAN domain containing 26
decreases expression
ISO
avobenzone results in decreased expression of ZSCAN26 mRNA
CTD
PMID:31016361
NCBI chr17:45,188,221...45,207,846
Ensembl chr17:45,188,248...45,207,065
G
Zscan29
zinc finger and SCAN domain containing 29
decreases expression
ISO
avobenzone results in decreased expression of ZSCAN29 mRNA
CTD
PMID:31016361
NCBI chr 3:113,119,729...113,131,148
Ensembl chr 3:113,120,703...113,130,171
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all